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Spinal cord injury causes a complete life change for patients and their social environment with 
severe economic, societal, and health implications. So far, there is no cure and only very limited 
treatment for patients suffering from spinal cord injury. Although central axons fail to regrow successfully 
after injury, incomplete spinal cord injury is accompanied by spontaneous but limited functional recovery. 
This recovery is attributed to compensatory neuroanatomical plasticity, where fibers remodel distal to 
the injury to establish new connections, so called neuronal detour circuits. Whilst various detour circuits 
in rodents are anatomically characterized in detail, the mechanisms of remodeling are not completely 
understood.  
Activity dependent processes, such as N-methyl-D-aspartate receptor (NMDAR) signaling, cyclic 
AMP response element-binding (CREB) transcription, and neuronal activity itself, play a crucial role in 
the formation of neural circuits during embryogenesis.  We analyzed the role of these processes in the 
cervical spinal cord, where the corticospinal tract has been demonstrated to sprout and contact novel 
target neurons after traumatic spinal cord injury. More specifically, we perturbed NMDAR signaling, (ii) 
suppressed CREB transcription, and (iii) silenced neurons with designer receptor exclusively activated 
by designer drugs (DREADDs).  
Inhibiting NMDAR and CREB function in the cervical area during detour circuit formation both 
resulted in anatomically aberrant remodeling of the corticospinal tract. However, cervical circuitry 
remained unaltered when activity dependent processes were manipulated before spinal cord injury and 
after a mature detour circuit had already been established. These experiments demonstrate that spinal 
cord injury transiently opens a critical window of activity dependent plasticity, enabling detour circuit 
formation.   
Furthermore, I argue that target selection during detour circuit formation after spinal cord injury is 
based on the neuron’s relative level of activity. Firstly, this interpretation is based on our observation 
that global cervical silencing had no measurable effects whilst selective silencing of specific neuronal 
populations created an anatomically and functionally defective detour circuit. Secondly, within this 
defective detour circuit, the degree of neuronal silencing negatively correlated with the likelihood of that 
neuron to be contacted by corticospinal tract collaterals. With the help of a detailed literature analysis, I 
demonstrate similarities in plasticity between the developing CNS, the adult intact, and injured CNS and 
propose future experiments. Taken together, this thesis illustrates that activity dependent processes 
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Steroids, in particular, methylprednisolone, were considered the only viable treatment for spinal 
cord injury (SCI) for 30 years. 1 More recent investigations into the original clinical data, 2,3 however, 
deem the use of the drug for SCI treatment ineffective. 4 Some have even reported severe risks of 
methylprednisolone treatment, such as the development of pneumonia or sepsis. 2,3 
Steroids against SCI present an example where preliminary results on functional improvements 
without anatomic data impacted treatment approaches too soon; they demonstrate the necessity of fully 
understanding natural pathological processes before inferring intervention effectiveness. If possible, the 
failure or limitations of interventions should be demonstrated before reaching expensive and lengthy 
clinical trials. In research on SCI, it is, thus, crucial to discern natural pathological processes and the 
central nervous system’s (CNS’) attempt to recover from these to optimize treatment effectiveness. In 
this dissertation, I will argue that SCI is a devastating disease with far reaching implications for those 
affected and society as a whole. I will present current knowledge on pathological processes induced by 
SCI and the CNS’ natural ability to remodel rather than regenerate following injury. Our experiments 
elucidate the role of neuronal activity in the process of remodeling. Finally, I will critically discuss these 
results and suggest future directions for SCI research on remodeling.  
EPIDEMIOLOLGY AND SYMPTOMS – SCI IS A DEVASTATING DISEASE  
With 40-80 in a million 
new cases of SCI each year, 5 
SCI is a universal disease, 
crossing borders of 
nationalities, age groups, and 
economic status when 
afflicting new patients. Case 
fatality of SCI before the end of 
initial hospitalization has been 
reported as 48%, with the 
majority of patients dying upon 
injury (Figure 1). 6 According to 
autopsy protocols, SCI is 
considered the primary cause 
of death in more than half of 
these fatal cases. 6 Although 
already alarming, even higher 
SCI fatality rates of more than 
50% are reached when 
including deaths caused by 
FIGURE 1 Short-term and long-term case fatality rates for SCI. Almost half of the afflicted 
patients die before the end of initial hospitalization (early deceased). The majority of 
these cases list SCI as the primary cause of death in the autopsy protocol. 6 When 
patients do survive, they develop severe physical and psychological symptoms, 
eventually leading to high long-term case fatality rates (late deceased). Death caused by 
pneumonia and influenza, septicaemia, diseases of the urinary tract, suicide, and 
cerebrovascular diseases are significantly increased in this SCI population when 
compared with a non-injured population of the same age. Long-term case fatality rates 
were calculated from standardized mortality ratios taken from ref. 7, which analyzed 
deaths in the SCI afflicted later than 18months after injury. Late survivors are SCI patients 
with the same life expectancy as individuals in a non-injured population. All data are  
based on studies conducted in developed countries. Case fatality rates might be higher 
in less developed areas.  
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later secondary pathological effects or cases of suicide, one of the leading causes of death after 
surviving the initial injury (see “late deceased”, Figure 1). 7  
Surviving the initial critical phase comes at the staggering personal cost of countless 
psychological symptoms and physical impairments. SCI severely affects informational exchange 
between the spinal cord and brain. The lost information can be of motor or sensory nature, leading to 
physical impairments below the injury site for the patients’ entire lives, with little prospect of relief. These 
impairments can be accompanied by a loss of autonomic functions, creating, for example, bladder, 
bowel, and sexual dysfunction. Patients, hence, remain dependent on social support, impacting not only 
their own quality of life but also that of their friends and family. Psychological symptoms can develop, 
ranging from mild changes, such as increased levels of distress and decreased levels of reported life 
satisfaction, 8 to additional severe conditions, like anxiety or depression. 9  
With largest traumatic SCI incidence rates in individuals in their twenties, 10 they pose a large 
economic burden on society. A recent estimation of the lifetime economic burden of one SCI individual 
in Canada amounted to $1.5-3 million, depending on the severity of impairments caused by the injury. 
11 These costs include direct costs, i.e., medical expenses to relieve symptoms of SCI, and indirect 
costs, caused by a loss of the patient’s productivity and income. Epidemiological analyses of SCI 
illustrate the necessity for and lack of appropriate SCI treatment, which could reduce the large 
psychological, physical, and socioeconomic burden, impacting patients themselves, their families, 
communities, and society. 
CLASSIFICATION OF TRAUMATIC SCI – INJURY LOCATION 
DETERMINES IMPAIRMENTS IN HUMANS AND RODENTS 
SCIs vary across patients and prompt different phenotypes. Neurologic deficits induced depend 
on injury location and severity, i.e., which vertebra covers the injury and which anatomical components 
of the spinal cord is damaged.   
The spinal cord, in humans, extends from the cervical vertebra 1 to the lumbar vertebrae 1/2 12; 
the more rostral the injury, the more detrimental the clinical outcome. Most cases of SCI occur in the 
cervical spinal cord due to its high mobility with small vertebrae and, hence, larger direct target areas 
for impact sources. 13 Unfortunately, injuries of this type also induce the strongest physical impairment 
(Figure 2A); often tetraplegia/quadriplegia develops – paresis of all four limbs. Injuries of lower spinal 
cord levels can induce paraplegia – paresis of the lower body. 
The completeness of the injury also impacts the severity of physical symptoms that manifest after 
SCI. Fortunately, in comparison to incomplete SCIs, complete lesions have become less prevalent since 
the mid 20th century. 14 This reduction is likely explainable by a superior emergency response, where 
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secondary injury is avoided by 
immobilization of the affected 
individuals, and improved 
diagnosis based on the 
integration of anatomic with 
behavioral data.  
The relationship 
between injury completeness 
and motor outcome is not 
linear.  Surgically induced 
spinal cord transections for 
intractable pain relief have 
provided insight into the motor 
impairments caused by 
different types of injuries. 15,16 
For example, a complete 
transection of the human 
ventral spinal cord at the 
thoracic level induces no or 
very minimal impairments in 
motility, whereas a mere 
unilateral transection of the 
posterolateral column, a 
relatively small strand of the 
dorsal spinal cord, leads to a 
complete paralysis of the 
affected limb. 16 Thus, the 
localization of the injury within 
a spinal cord transection 
determines which neural tracts 
are transected and, hence, 
which symptoms manifest. 
LESIONING THE CST 
In humans, transections of the posterolateral column induce such severe impairments because it 
includes the majority of the corticospinal tract (CST), the lateral CST. 12 Due to the importance of the 
CST for human motor control, our experiments in rodents focus on exactly this descending motor tract. 
Aside from the lateral CST, a smaller medial CST runs in the central column of the spinal cord (Figure 
2B). 12 Both components originate in several areas of the cortex. 17 The motor cortex is somatotopically 
organized, so that it consists of forelimb and hindlimb motor areas, responsible for the activation of 
FIGURE 2 Anatomy of the human and mouse spinal cord, illustrating the relationship of 
injury location and symptom severity. The whole spinal cord (A) and its zoomed in 
coronal sections (B) are color coded in shades of blue where the darkest shade indicates 
that a lesion to this area would lead to the severest motor symptoms and the lightest 
shade to the mildest symptoms. The mouse vertebral column is based on a micro CT 
scan, with permission from ref. 185.  The human vertebral column is adapted, with 
permission from ref. 186. 
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different sets of muscles. Restoration of CST function after injury would lead to grave improvements in 
symptoms of patients. 
In rodents, the CST consists of three components, a dorsomedial, a ventromedial, and a 
dorsolateral component (Figure 2B). 12 The vast majority (~95%) of all CST fibers run in the dorsomedial 
component, in the ventral part of the dorsal column, rendering all CST fibers after an injury to this area 
almost completely transected. Contrary to observations in humans, rats with a lesioned dorsomedial 
CST do not exhibit a complete paralysis of limbs but merely difficulties in fine movements, such as paw 
placement. 18 When assessing the effect of interventions to increase CST functionality after injury, fine 
motor skills have to be considered in rodents and gross motor skills in human patients.  
PATHOPHYSIOLOGY – SCI INDUCES A CELLULARLY DAMAGING 
CASCADE  
SCI follows a biphasic pathophysiological process, composed of a primary and a secondary injury. 
The primary injury is the initiator - the mechanical injury that is caused by an insult on the back, its 
resulting broken bone or intervertebral disk displacement, and the contusion, compression, distension, 
or, in rare cases, transection of the spinal cord. Ascending and descending pathways, neuronal cell 
bodies, glial cells, blood vessels, and the dura can be harmed in the process.  
The primary injury, then, cascades into a long-lasting, progressive secondary injury, which is 
characterized by cellularly damaging or even lethal processes (Figure 3A). While the primary injury can 
merely be prevented, if at all, the secondary injury can be modified by disease interventions. In the 
following, I will outline some of the major challenges the spinal cord faces during secondary injury and 
use examples of pathophysiological modulation in rodents to illustrate the complexity of the CNS’ 
response to SCI.  
As previously indicated, tract damage composed of axons determine the functional outcome 
following SCI. Understanding the processes in which axons dieback after injury is, hence, crucial for 
designing SCI treatment. After injury, axons remain stable for a short period. 19 In vivo imaging of the 
real-time effects of axonal transection has revealed that two minutes after injury, though, axons already 
start dying back through different processes: (1) pore-induced axonal loss, (2) axonal retraction, and (3) 
Wallerian degeneration. During pore-induced axon loss after contusion, mechanopores in the 
membrane allow the sudden influx of calcium, causing swelling, and eventually fragmentation of the 
entire axon. 19 Pore-induced axon loss and axonal retraction both happen only up to hours after SCI and 
damage the entire axon. 20,21 In contrast, Wallerian degeneration occurs up to weeks later and only 
affects part of the axon that is distal to the injury, without connection to the cell body. 20,22 Wallerian 
degeneration has also been seen to spread to intact, uninjured axons neighboring the SCI. 23 The 
primary injury alone, hence, is not conclusive of the lost connections between brain and spinal cord. The 
true extent of denervation in rodents will only manifest weeks after the insult to the spinal cord.  
Although some axons may remain intact following SCI, they fail to conduct signals efficiently. 
Oligodendrocytes, which usually isolate axons with myelin and streamline signal conduction, also 
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undergo apoptosis following SCI. 24,25 This cell death causes demyelination up to weeks after the primary 
injury. One study has shown that demyelination exposes axons to further damage and could induce 
axonal degeneration later on. 26  
As aforementioned, primary injury can not only damage nervous tissue but also blood vessels 
that usually supply the injured region of the spinal cord with nutrients and oxygen. Vascular damage 
results in reduced blood perfusion of the affected region, so called ischemia. Ischemia leads to a quick 
depletion of the CNS’ limited energy reserves and the loss of ionic homeostasis, eventually causing 
increased cell death in the injured spinal cord.  
Damage to blood vessels also harms the blood-brain barrier, 27–29 allowing immune cells to enter 
the injury site and subsequently aiding in a severe, persistent inflammatory response. Manipulating the 
immune response in the spinal cord after injury has generated seemingly conflicting observations, where 
either positive or negative effects on disease outcome were reported. 30,31 For example, microglia are 
one of the first immune cells to respond to SCI, and their activation has long been considered detrimental 
to disease pathology. Several studies could show that antagonizing cytokines produced by microglia 
activation reduces tissue damage and apoptosis following SCI. 32–34 New research, however, indicates 
that microglia can be activated disparately, resulting in a neuroprotective impact on disease outcome. 
35,36 Hence, the immune cell’s effect on SCI depends on the pathway by which it is activated and cannot 
be bluntly declared as good or bad for the disease.   
Research on the immune response following SCI has also revealed the determinant role of 
genetics and age in disease pathology. Different rodent strains vary in their magnitude or chronology of 
immune response. For example, C57Bl/6 mice, a mouse strain used in this thesis’ experiments, 
activates an increased number of microglia following SCI when compared to another common mouse 
strain, BALB/c. 37 Immune responses to SCI are also influenced by differences in age. 38,39 Pathological 
differences due to a genetic or age-related heterogeneity need to be considered in the development of 
treatment and their appropriate use by spinal injured individuals.  
Cell death triggered by ischemia and the primary injury causes the excessive release of 
glutamate, initiating excitotoxicity. 40  When applying glutamate in a trauma comparable dose on healthy 
spinal cords, one can reproduce secondary injury-like neuronal cell death. 41 This lethality is explained 
by glutamate’s hyperstimulation of neurons and glia cells as well as the resulting excessive uptake of 
calcium into the affected cell. High levels of intracellular calcium harm the cell or the axon during the 
aforementioned pore-induced axonal loss by activating enzymes that destroy crucial cell structures or 
eventually cause apoptosis. 42,43 Calcium induced glial and neuronal death increases extracellular 
glutamate levels even further, initiating a vicious cycle of excitotoxicity. Scientists have shown that 
breaking the cycle of excitotoxity by blocking glutamate receptors, and more specifically, N-methyl-D-
aspartate receptors (NMDARs) with the antagonist MK801, right after SCI, leads to a positive behavioral 
outcome in rats. 44 As explained later in the results section of this dissertation, we have observed 
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contrary effects of MK801, 
where the drug worsened SCI 
pathology. These conflicting 
results illustrate the 
importance of intervention 
timing. In our study, we 
administered the drug when 
excitotoxicity had already worn 
off.  
To conclude, knowledge 
on secondary injury pathology 
highlights the severity and 
complexity of this damaging 
cascade and has taught 
valuable lessons for future 
research: (1) researchers 
should defer from the 
simplification of evaluating 
certain pathophysiological 
phenomena as either good or 
bad, (2) genetics and age 
impact SCI pathology, and  (3) 
timing as well as localization of 
putative interventions are 
crucial.  
DAMAGED AXONS FAIL TO REGENERATE SPONTANEOUSLY & 
INTERVENTIONS ARE CHALLENGING 
Aside from reducing the damaging effects of the secondary injury on SCI outcome, rebuilding lost 
connections via axon regeneration could also induce recovery.  In contrast to lesions to the peripheral 
nervous system, the CNS fails to reinstate original circuitry after injury and degeneration, impeding 
functional recovery. In vivo imaging in mice has provided great insight on the central axons’ severely 
limited regenerative processes in response to injury. A minority of proximal axons, i.e. the part of the 
axon still attached to the cell body, grows hours to days following the lesion. 20,45 This outgrowth, 
however, is merely an unsuccessful attempt to reinnervate previously lost connections. The majority of 
axonal sprouts grow aimlessly and have a severely reduced caliber with many side branches. 20,23 In 
addition, oligodendrocytes try to remyelinate axons after SCI but only generate abnormal, thin sheaths. 
24 More mature seeming axons with straighter trajectories might reach the initial lesion site a week post 
injury only to find their distal end completely degenerated with no opportunity to reconnect. 45  
FIGURE 3 SCI induces a cellularly damaging secondary injury, which impedes on 
regenerative attempts by the CNS. (A) Processes supporting cellular damage after SCI. 




Both the central axon’s intrinsic and extrinsic composition hinder central axon regeneration after 
SCI, which can be elucidated by two experiments. First, when solely changing the environment of 
lesioned central axons by implanted regeneration-supportive peripheral nerve grafts, a substantial 
amount (20%) of central axons can regenerate successfully along the graft. 46 A second set of 
experiments demonstrates that intrinsic regeneration processes can be activated independently from 
the spinal cord’s environment.  Dorsal root ganglion neurons with a central branch projecting to the 
spinal cord can be conditioned to regenerate if their peripheral branch was lesioned beforehand. 47 In 
the following, I will first briefly summarize SCI interventions in rodents tackling obstacles of regeneration 
(Figure 3B), rooted in a regeneration-hostile environment and the intrinsic inability to regenerate. 
Secondly, I will discuss potential shortcomings of those interventions.  
MODIFYING THE EXTRINSIC REGENERATION INHIBITORY MILIEU  
While peripheral axons, whose conduction is isolated by Schwann cells, can regenerate, central 
axons, wrapped in myelin sheaths, fail to regenerate. Likewise, cultured neurons do not grow axons on 
top of myelin extracts but exhibit high affinity for axon outgrowth on nerve explants containing Schwann 
cells. 48 The first molecule found to be responsible for myelin’s inhibitory impact on axonal outgrowth 
was Nogo-A, which was soon followed by others, such as myelin associated glycoprotein and 
oligodendrocyte myelin glycoprotein. Approaches neutralizing myelin-derived growth-inhibitors have 
been deemed successful by inducing axon regeneration beyond the spinal cord lesion in multiple 
settings. 49–52  
Peripheral regeneration does not only profit from the absence of myelin but also from the 
presence of Schwann cells and their secretion of growth-promoting neurotrophic factors. Thus, 
transplanting Schwann cell grafts into the spinal cord can remyelinate  severed axons and induce limited 
regeneration of thicker and more robust central axons. 53 The Schwann cells’ secretion of growth-
promoting neurotrophic factors usually guides and promotes axon outgrowth during development and 
after peripheral injury. 54–56 When added to injured spinal cords, a myriad of neurotrophic factors can 
recapitulate developmental growth processes. 57–61 Instead of mere topical administration of growth 
factors, implanted Schwann cells can also be genetically engineered to hyper-secret further growth 
factors yielding strongest axon regeneration after SCI. 62,63 
Glial cells are also an important component of the change in extracellular milieu after SCI; they 
form a scar around the primary injury to seal it and isolate damage. 64,65 However, the glial scar also 
creates an impenetrable barrier for axonal regeneration due to its density and release of inhibitory 
factors. 66–68 A well-studied inhibitory family is chondroitin sulphate proteoglycans, which has been 
neutralized with the enzyme chondroitinase ABC 69 or by genetically removing enzymes crucial for the 
factors’ proper mechanism of action. 70,71 Neutralizing the glial scar associated inhibitory factors can aid 





MODIFYING THE INTRINSIC CAPABILITY TO REGENERATE 
Neural stem cells can be a supportive structure for the regeneration of host axons. Likewise, 
neural stem cells have been used to replace previous connections. For example, when transplanting 
neural stem cells into the spinal lesion within a supportive fibrin matrix, neural stem cells can grow axons 
with lengths up to 25mm, which outshines all previous interventions yielding outgrowth of 1-2mm. 72 A 
neural stem cell approach can, hence, aid in modifying the regeneration inhibitory intra- and 
extracellular.   
The contrast in regeneration capabilities of peripheral and central axon is based on different gene 
expression after injury. Gene expression analyses have provided great insight into how certain signaling 
pathways can activate an axonal regeneration-enabling program after peripheral nerve injury. Applying 
knowledge from the peripheral nervous system to the injured CNS by targeting genes involved in growth 
associated signaling pathways has proven promising. For example, manipulating growth supportive 
transcription factors, which coordinate the expression of multiple genes, in central neurons of the injured 
spinal cord has promoted axon outgrowth in a myriad of settings. 73–77 Studies where growth associated 
transcription factors are upregulated could also illustrate that regeneration is a dynamic process. 
Upregulating the transcription factor STAT3 in injured central axons, for example, only aids in the 
initiation but not the maintenance of regeneration. 73 This interpretation was further supported by deleting 
STAT3 in regenerating peripheral nerves where axonal outgrowth was delayed but not completely 
abolished. 73 The study indicates that gene expression highly varies during phases of regeneration; it 
stresses the importance of time conscious analyses and poses another challenge for successful 
intervention to increase regeneration.   
An additional distinction between injured central and peripheral axons is the cytoskeleton’s 
stability. The cytoskeleton, responsible for the transport of subcellular machinery, e.g. organelles, new 
cytoskeletal components, lipids, and proteins, allows for the typical growth cone formation and thereby 
axon outgrowth following peripheral nerve injury. However, microtubules, a major component of the 
cytoskeleton, destabilize in central axons upon injury. 78 Administering drugs that stabilize microtubules 
has been shown to prevent axonal degeneration and support regeneration after SCI. 79–81 
ISSUES WITH REGENERATION SUPPORTIVE INTERVENTIONS 
Although all previously outlined interventions could boldly be summarized as yielding increased 
regeneration following SCI, the extent of those effects is quite limited. Neutralizing the growth-inhibitor, 
Nogo-A, for example, only increases regeneration in 5% of the injured axons 49 – a minimal proportion 
compared to an astounding 90% of naturally regenerating peripheral axons. 82 Furthermore, outgrowth 
length in the few axons that do regenerate is also only increased minimally through intervention. In 
humans, regenerating spinal cord axons need to overcome even larger distances to induce functional 
improvement, which poses an additional challenge for the effectiveness of already limited regeneration-
supportive interventions.  
Axonal outgrowth by itself cannot lead to functional improvements and is, therefore, not the sole 
determinant of functional recovery. The leap in regeneration after neural stem cell transplantation 72 or 
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after the combination of several interventions 83 did not cause a leap in behavioral benefits when 
compared to results from previous interventions. In fact, many experiments with minimally increased 
axonal outgrowth could, nonetheless, link it to some positive behavioral effect after SCI, such as 
improved motor recovery. A possible explanation for this phenomenon is that regeneration length does 
not correlate highly with motor recovery, and only a small proportion of a motor tract needs to be intact 
for it to function properly. These observations demonstrate that the search for successful intervention 
needs to move beyond sheer axonal outgrowth and deal with the establishment of original neural 
circuitry to achieve complete functional recovery. Thus, besides stimulating regeneration, neurons need 
to survive and regenerate with direction, where contacts onto newly denervated neurons are restored. 
All these components are required but by themselves not sufficient for successful intervention.  
When evaluating the success of interventions, functional data are indispensable. Functional data 
can be acquired by measuring neuronal activity, such as electrophysiology, histochemistry or in vivo 
calcium imaging, or can be represented directly with behavioral experiments. Still, increased behavioral 
recovery itself does not prove that they were caused by the investigated anatomic alterations. Instead, 
re-lesioning or silencing experiments are necessary to demonstrate a causal relationship between a 
specific anatomic alteration and behavioral outcome.    
An alternative cause for functional recovery induced by regeneration supportive interventions 
could be the alteration of disregarded neural circuits as an off-target effect. In addition to the 
regeneration of central injured axons after SCI, spared axons might reorganize. In fact, many studies 
could show how increasing regeneration with established growth-enhancing interventions was 
concomitant with increasing remodeling. Reportedly, enhancing the growth associated mTOR pathway, 
76 upregulating transcription factor KLF7 74 or STAT3, 73,84 neutralizing a glial scar associated inhibitory 
factor with chondroitinase ABC, 85  and neutralizing myelin associated growth inhibitor NogoA 50 have 
all been shown to also boost remodeling. These modulations indicate that axonal outgrowth processes 
in regeneration and remodeling might underly similar mechanisms. Some studies even failed to induce 
any increased regeneration in injured axons after SCI by neutralizing all three myelin associated growth 
inhibitors 86,87 and could only demonstrate increased growth of spared axon collaterals distal to the injury. 
87 In order to completely understand an intervention’s effect on SCI pathology, it is crucial to examine 
alterations in regeneration, remodeling, and behavior. Former re-lesioning studies or state-of-the-art 
silencing experiments, as used in this thesis, present a powerful tool in investigating which anatomic 
alteration is responsible for behavioral recovery.   
To summarize, axons in the spinal cord fail to regenerate after injury due to extrinsic factors and 
intrinsic incapability. Much focus has been directed towards interventions that aid in overcoming these 
barriers and achieving regeneration. However, regeneration is only one aspect of anatomic alteration 
that could aid in behavioral improvements. Tackling remodeling of intact neural circuits distal to the 
lesion alongside its destabilized cytoskeleton, inhibitory glial scar, and damaging cytokines is a 




THE HUMAN CNS REMODELS CHRONICALLY AFTER SCI 
Patients suffering from incomplete SCI exhibit limited spontaneous recovery without intervention. 
This limited recovery can be strengthened by physiotherapy. Patients with treadmill training, for 
example, regain rhythmic patterns of locomotor muscle activation and decrease their muscle spasticity. 
88 In total, treadmill training by itself increases the number of independent walkers by 42% in patients 
with incomplete SCI. 89 These observations are certainly not based on, as in the previous chapter 
described, failed regeneration nor can they be explained entirely by increased muscle strength, but 
instead result from different types of CNS remodeling. Although SCI severely restricts the transmission 
of signals between the brain and spinal cord, a bulk part of neurons involved in the healthy transmission 
process survive and continue to respond to synaptic input. Intact neurons present a powerful possibility 
in overcoming signaling barriers and inducing recovery of function after SCI by CNS remodeling. 
For the purpose of this thesis, I define CNS remodeling as a chronic response to SCI where 
uninjured neuronal circuits are altered, resulting in a long-term increase in activation of certain central 
neurons or entire areas. These uninjured circuits can be altered structurally and/or functionally. 
Structural remodeling entails changes in diameter or length, viz. sprouting, of axon collaterals or 
dendritic branches, where new synapses and, hence, new circuits can be formed. Functional remodeling 
can be achieved by changes in neuronal excitability, synaptic strength or changes in glial activity.  
In humans, studies could verify the occurrence of remodeling after SCI but not determine how it 
developed. Specifically, changes in activation of certain CNS areas in SCI patients in comparison to a 
healthy population can be measured with non-invasive techniques such as positron emission 
tomography, 90 functional magnetic resonance imaging, 91–97 or transcranial magnetic stimulation. 98–101 
Invasive techniques used in rodent studies are clearly not applicable to human patients, which averts 
inferences on the structural or functional nature of remodeling.   
Many neurons in the brain are not directly affected by SCI, and yet some can reorganize upon 
injury. These remodeling effects have been shown to increase with exercise. For example, motor 
recovery in patients with incomplete SCI following treadmill training correlates with an increase in CST 
connectivity. 102 Several other studies have compared healthy and SCI subjects to show increased 
activation of motor areas during actual or even imagined movement. 90,94–96 This increase in activity also 
includes completely novel activation of brain areas that are inactive during movement in healthy 
subjects. For example, motor cortex areas that activate during movement of functional body parts, rostral 
to the SCI, have been observed to expand into a deafferented part of the motor cortex formerly activated 
for the movement of now paralyzed body parts. 93 Similarly, studies using transcranial magnetic 
stimulation show that an expanded area of the motor cortex can excite motor neurons in muscles of 
functional body parts. 99–101 It is hypothesized that the activation shift in the cortex could aid in maximizing 
outputs of movement since it has been shown to increase with rehabilitation. 97,98 These experiments 
demonstrate the functional benefit this type of remodeling can offer.   
However, remodeling upon SCI does not necessarily translate into recovery but can have 
negative consequences, like observations in remodeling of the somatosensory cortex revealed. Similar 
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to the motor cortex, the somatosensory area’s lost input from denervated body parts are replaced by 
input from neighboring sensorially intact body regions. 91,92 One study found that the extent of this 
somatosensory remodeling correlates with neuropathic pain of the denervated body parts. 91 The 
generation of deafferentation pain following SCI shares similar mechanisms with phantom limb pain 
after amputation. 103,104 These human experiments investigating remodeling in the somatosensory and 
motor cortex following SCI illustrate how remodeling can be an obstacle or a great asset in trying to 
relief SCI related symptoms.  
KNOWLEDGE OF CNS REMODELING IN RODENTS AIDS IN OPTIMIZING 
SCI INTERVENTIONS 
The potential of the animals’ CNS to undergo spontaneous remodeling without intervention 
following SCI has been long established and repeatedly reaffirmed. Early experiments also provided 
evidence for remodeling through functional data, i.e. rehabilitation after SCI. Researchers could help 
cats regain stepping abilities after complete transections by training them on treadmills. 105,106 Soon, 
studies showing the positive effect of locomotor training on SCI recovery in rodents followed. 107–109 
In contrast to human studies, rodent studies can clearly include more invasive techniques, which 
help in widening our understanding of remodeling. Rather than making inferences on remodeling upon 
changes of activation in the CNS, researchers can visualize entire detour circuits formed through 
remodeling processes directly. Below, methodological differences within rodent studies investigating 
SCI induced remodeling are outlined concerning the injury model, behavioral assessment, and tracing 
method.  
METHODOLOGY OF RODENT REMODELING STUDIES 
When studying remodeling, induced SCIs need to be incomplete. Some remodeling studies use 
a contusion injury model as it is most clinically relevant; it mimics most injuries in humans where a force 
from outside of the body compresses the spinal cord. Varying the strength, size, and duration of the 
compressive force defines the extent of SCI. Alternatively, most remodeling studies, like the ones 
presented in this thesis, have opted for an incomplete transection. Transecting the spinal cord allows 
researchers to controllably injure a specific part of the spinal cord where they are not limited to a dorsal 
approach, but could also, for instance, perform a lateral hemisection. Although this injury model does 
not mirror what occurs in most human patients, it presents a very powerful approach due to 
reproducibility.  
The largest advantage of animal models in studying remodeling after SCI is our ability to visualize 
remodeled neuronal networks with fluorescence microscopy. Scientists have countless methodological 
options to choose from when deciding how to make remodeled networks fluorescent. Bareyre and 
colleagues, for example, have opted for creating a transgenic mouse line that expresses a fluorescent 
protein in the entire CST. 110 The oldest and simplest method to track any neuronal projections, though, 
is the application of molecular tracers. With a local injection into the region of interest, neurons take up 
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the tracers and transport them antero- or retrogradely over a time course 
ranging from days to weeks. Whereas anterograde tracers are 
transported from the soma to axonal endings (Figure 4A), retrograde 
tracers move in the opposite direction (Figure 4B). Injecting anterograde 
tracers, such as biotinylated dextran amine (BDA) allows for the 
visualization of entire axonal projections and where they remodeled. In 
the case of the motor cortex, adjusting the injection coordinates along 
the mediolateral and rostroventral axis, even results in distinct labeling 
of either the hindlimb or forelimb CST. Retrograde tracers, such as 
hydroxystilbamidine (FluoroGoldTM), can show which neuronal 
populations after SCI sprout at the injection site. Applied together, one 
can prove whether the anterogradely labeled sprouting collaterals form 
contacts onto a retrogradely labeled neuronal population after SCI.  
Aside from molecular tracers, researchers’ tracer toolbox also 
includes recombinant viral tracers that drive the expression of 
fluorescent proteins, such as the most commonly used adenoassociated 
virus (AAV). Similar to molecular tracers, static viral tracers can label 
single connections anterogradely or retrogradely (Figure 4 A and B); 
they are, thus, a great tool to determine sprouting of one neuronal 
population. 111 Moving beyond tracing, viral vectors are a powerful tool 
to genetically manipulate neurons in remodeling circuits.  
Moreover, viral tracers can target very defined neuronal subtypes 
by combining site-specific recombinase technology, such as the cre-lox 
recombination system. The effect of cre recombinase binding to its lox 
sites depends on the relative orientation of the lox sites. In this thesis, 
for example, we use a mouse line with two lox sites oriented in the same 
direction surrounding a gene of interest. When cre recombinase 
expression is induced by AAV injection, our gene of interest is excised. 
In addition, we make use of a double-floxed inverse orientation (DIO) 
AAV where an inverted fluorophore sequence is surrounded by opposing lox sequences. If cre 
expression is, then, induced with another AAV or a transgenic mouse line, the inverted fluorophore 
sequences will be flipped, and the fluorophore is successfully expressed. For intersectional labeling, we 
combined the anterograde DIO-AAV with a retrograde cre-AAV. Thereby, only neurons with a soma at 
the site of anterograde AAV injection and axon terminals at the site of retrograde AAV injection will be 
manipulated or traced (Figure 4C).  
Evaluating functional rather than just structural remodeling in rodents can be, amongst others, 
accomplished by electrophysiological recordings or markers of neuronal activity, such as a staining for 
the synaptic marker synapsin. The most direct way of proving the functional relevance of underlying 
structural remodeling is behavioral assessment. Naturally, functional changes due to motor tract 
remodeling involve motor rather than sensory behavior. The oldest motoric assessment applied in motor 
FIGURE 4 Tracing methodology 
applied in remodeling studies after 
SCI. (A) Anterograde tracer/virus 
illustrates where a labeled population 
sprouts. (B) Retrograde tracer/virus 
illustrates which populations sprout 
in a particular area. (C) Combining a 
cre-dependent anterograde virus 
with a retrograde cre-inducing virus 
allows for intersectional labeling; it 
specifically labels neurons with a 
soma at the anterograde viral 
injection and projections at the 
retrograde viral injection. Magenta 
halo: injection site of tracer with 
fluorophore, gray halo: injection site 
of cre-inducing retrograde virus. 
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tract remodeling studies is the Basso, Breasie and Bresnahan locomotor scale for rats and the Basso 
Mouse Scale. Researchers classify motor recovery on a point scale that evaluates rather gross hindlimb 
function. 112,113 It is, hence, used in studies with thoracic injuries where only hindlimbs are affected and 
changes in motor skills are severe. The subjectivity introduced by the researcher’s evaluation make the 
data more variable. 114 Another test for locomotor recovery is the horizontal ladder walking test. 114 In 
this test, mistakes a mouse makes when crossing a horizontal ladder are counted. It is an easy and 
cheap test, which is widely applied in SCI remodeling studies. The readout in these studies, however, 
is limited. New computer assisted gait analyses benefit from the high sensitivity in vast types of readout, 
from fine to gross motor changes, and the reduction of inter-rater variability. A three-dimensional 
analysis of locomotion is achieved via camera recordings of the rodent from multiple angles. 115 This 
method allows tracking of entire locomotor profiles after SCI. Yet, three-dimensional recordings plus 
analysis require expensive equipment and are time consuming. To assess the behavioral effect of our 
intervention on remodeling in this thesis, we have chosen another objective and sensitive, though 
cheaper, computer assisted gait analysis: the CatWalk. 116 In the CatWalk test, rodents walk on a 
specially illuminated glass platform that is recorded from below. This setup together with computer aided 
extraction allows the analysis of rodent paws placed on the ground.  
The variety in parameters, from print area through stride length to speed, generated by computer 
assisted gait analyses like CatWalk, comes with a downside of a high-dimensional, large dataset.  
Reducing the dimensionality with a principal component analysis (PCA) aids in interpreting the data by 
summarizing the biggest variance between all mice. A simple example (Figure 5A and B) shows that a 
PCA can simplify data without losing much information (99.2% of data variance is represented in the 2D 
graph, Figure 5C and D), can help in recognizing differences between experimental groups, and offers 
loadings to potentially assign differences to certain parameters (Figure 5E). In this example, I could 
reduce dimensionality by one, which might not seem particularly powerful. In a real CatWalk experiment, 
like the one presented in this thesis, we can often reduce dimensionality from 200 to 2 without losing 




FIGURE 5 Example CatWalk data explaining PCA to reduce 3D to 2D datasets with marginal information loss. (A) Three CatWalk 
parameters from four mice. (B) Raw data is plottable in a 3D graph. (C) PCA allows for plotting the same data in a new 2D 
coordinate system with calculated PCs on the axes. Experimental groups differ in PC1 rather than PC2. (D) PCA induced limited 
information loss; total variance of the entire data set explained by the first two PCs is 99.2%. (E) Factor loadings explain how 
much a parameter correlates (values from -1 to 1) with a PC. Speed and print area correlate highly with PC1, which explains the 




TRACING STUDIES OF SPONTANEOUS REMODELING IN RODENTS AFTER 
TRAUMATIC SCI 
The capacity of the CNS to compensate for the SCI induced loss of 
neuronal connections has been demonstrated in various settings, 
involving different populations of neurons. Remodeling, just like severity 
of SCI symptoms, depends on the location and completeness of the 
lesions. Motor tracts originating in the brain stem, such as the 
reticulospinal tract or vestibulospinal tract, have been shown to remodel 
in response to lateral hemisections. Fibers originating on the ipsilesional 
side bridge the lesion by crossing to the contralesional side rostrally, 
only to sprout back to the ipsilesional side below the lateral hemisection. 
117,118 Similarly, fibers originating in the contralesional brain stem remain 
on that side of the spinal cord until beneath the lesion where they, then, 
also sprout to the ipsilesional side at various levels of the spinal cord 
(Figure 6A). 119 Even after severe contusions, where almost all of the 
spinal cord is damaged, spared fibers of the reticulospinal tract sprout 
below the injury (Figure 6B). 120 While these experiments prove that 
brain stem motor tracts are able to sprout, they do not investigate, which 
cells are contacted by the sprouting fibers. Just as in regeneration, 
extension of axonal length alone without contact formation does not 
generate crucial functional improvement.  
To facilitate recovery, sprouting motor tracts must either contact denervated motoneurons directly 
or contact interneurons of the spinal cord, which in turn make connections with motoneurons. These 
interneurons belong to the category of propriospinal neurons (PSNs), which lie completely in the spinal 
cord, passing on information over short and long distances. After lateral hemisections, PSNs with a 
soma above the injury and spared projections traveling along the contralesional side have been shown 
to sprout to the ipsilesional side below the injury (Figure 6C). Killing these PSNs after they have 
remodeled eliminates behavioral recovery. 121 A subset of these PSNs with a soma on the ipsilesional 
side have been reported to receive increased input by brain stem motor pathways. 122 These studies 
indicate that PSNs are key players in successful remodeling after SCI. However, without identifying 
further connections to motoneurons, complete detour circuits with the ability to induce functional 
recovery remain undiscovered.  
The CST and its capacity to remodel has long been at the center of chronic SCI research in 
rodents. Various experiments show the CST’s capacity to sprout within weeks of the lesion inflicted. It 
was demonstrated that the ventromedial CST responds to a cervical injury of the dorsomedial CST by 
sprouting above the lesion and contacting motoneurons directly (Figure 7A). These new connections 
enable functional recovery in injured rodents. 123 Bareyre and colleagues extend the observation of 
remodeling to the ventrolateral CST. They show how injuring the major CST at a thoracic level leads to 
sprouting of both minor CSTs below the lesion where they contact motoneurons directly (Figure 7B). 110  
FIGURE 6 Remodeling involving 
brain stem motor tracts after SCI. (A) 
and (B) show the capacity of brain 
stem motor tracts to sprout. (C) 
Sprouting brain stem motor tracts 
can contact PSN, which sprout 
themselves to bridge the injury. 
Illustrations based on (A) ref. 





Thus, minor components of the CST can structurally and functionally take over the much more nominal 
dorsomedial component of the CST. 
Consisting of a number of fibers far beyond the minor CST components, the dorsomedial CST’s 
capacity to remodel is of particular interest. After a lateral hemisection, the fibers on the contralesional 
side have been shown to sprout to the ipsilesional side at various levels below the injury (Figure 7C). 
124 Even when both sides of the major CST are injured, the hindlimb CST starts sprouting cervically 
(Figure 7D). 125,126  
Most detailed anatomical remodeling in rodents was characterized after a thoracic dorsal 
hemisection where an entire detour circuit could be traced, which reconnects a motor tract with its 
original, denervated motoneurons in the lumbar spinal cord via PSNs. As early as three weeks following 
injury, the hindlimb CST sprouts cervically to contact PSNs. A specific population of PSNs, long 
propriospinal neurons (LPSNs), are preferentially contacted, which project via the unlesioned ventral 
spinal cord to the lumbar region. These LPSNs, in turn, increase their contacts onto lumbar motoneurons 
(Figure 7E). 126 Relesioning the CST after remodeling took place reinstates early-injury motor 
deficiencies, highlighting the tract’s role in functional recovery after SCI. Because of the detour circuit’s 
uniquely detailed characterization, it offers wide opportunities to study remodeling mechanisms 
pertaining to sprouting and contact or synapse formation. Experiments described in this thesis make 
use of this detour circuit as an example to draw conclusions about general mechanisms of remodeling 
after SCI.  
FIGURE 7 The CST exhibits robust remodeling capacities after SCI. (A) and (B) show the capacity of the minor CST components 
to remodel after injury to the major dorsomedial CST. (C) The dorsomedial CST sprouts to the unlesioned side after a unilateral 
hemisection. (D) and (E) the injured hindlimb dorsomedial CST sprouts above the lesion. (E) An entire CST detour circuit was 
identified after a thoracic dorsal hemisection. The hindlimb dorsomedial CST sprouts above the lesion to contact LPSNs, which 
sprout lumbarly to increase their projections onto motoneurons. Relesioning experiments show that this detour circuit is (partially) 
responsible for motor recovery after SCI. Due to its detailed description involving functionally relevant sprouting and contact 
formation, it is the basis for experiments presented in this thesis. Illustrations are based on (A) ref. 123, (B) ref. 110, (C) ref. 124, (D) 




The rodent CNS’ capacity to remodel spontaneously after SCI has been proven extensively. 
However, spontaneous remodeling does not lead to full functional recovery, yet. Research on 
interventions to support the already promising intrinsic capacity of the CNS to remodel after SCI is 
becoming increasingly popular.  Aside from the aforementioned molecular interventions (targeting 
mTOR, KLF7, STAT3, chondroitin sulphate proteoglycans, and NogoA) that increase remodeling as well 
as regeneration, there are interventions that specifically target remodeling.   
As previously described, rehabilitative training, like treadmill training, wheel running or pellet 
reaching, has been observed to improve motor functions in rodents. 107,108,127 This behavioral 
improvement was later attributed to increased sprouting of motor tracts above and below the lesion, 
107,109,127 more directed sprouting to new areas of the spinal cord, 128 as well as increased contact 
formation between motor tracts and PSNs or motoneurons. 107 Increased remodeling after rehabilitation 
could be explained by altered gene expression profiles in areas of remodeling, inducing changes in 
growth factors, guidance molecules, and components of synaptogenesis. 128 Electrostimulation and 
pharmacological stimulation of areas with sprouting collaterals have also been shown to support 
remodeling. For example, positive effects of rehabilitative training can be further improved by combining 
it with epidural stimulation and serotonergic plus dopaminergic antagonists, both applied to remodeling 
supportive areas of the spinal cord. 120,129 Although this multifaceted approach has yielded, so far, 
maximal functional recovery, reaching levels of uninjured motor skills, that can be used at the rodent’s 
own volition, can, still, not be accomplished.  
OBJECTIVES 
Optimizing interventions that target the CNS’ already promising remodeling response is only 
possible if we completely understand the exact mechanisms underlying remodeling. Rehabilitative 
training, electrostimulation, and pharmacological stimulation, which specifically act on remodeling, 
rather than regeneration, all impact neuronal activity of certain spinal cord populations. In these setups 
neuronal activity was increased indiscriminately, disregarding neuronal populations. Moreover, 
anatomic analyses were limited to general changes to sprouting or contact formation.  
Before publishing our paper in the Journal of Experimental Medicine, the exact role of neuronal 
activity in remodeling after SCI, however, remained to be elucidated. For the first time, we analyzed the 
importance of neuronal activity for CST remodeling after SCI in experiments, which will be presented 
and elaborated on in this thesis. 130 
To understand spontaneous remodeling, we decreased neuronal activity or activity dependent 
processes chronically in a well-known detour circuit after SCI (Figure 7E). After a thoracic dorsal 
hemisection, manipulations were performed in the spinal cord at the location of CST sprouting plus 
contact formation onto PSNs and entailed: (1) perturbing NMDAR transmission, (2) inhibiting the activity 
dependent cyclic AMP response element-binding protein (CREB) mediated transcription factor, and (3) 




Resulting changes to remodeling were quantified anatomically at the site of intervention, in terms 
of changes to CST collateral sprouting (by analyzing CST collaterals exiting the white matter to the gray 
matter and measuring total collateral length in the gray matter), collateral maturity (by analyzing bouton 
density along CST collaterals) and contact formation onto relay neurons. Functional remodeling was 
assessed using the aforementioned CatWalk experiment.  
With this experimental setup our work elucidates the role of neuronal activity in detour circuit 
formation after SCI by answering the following questions:  
1. How does perturbing NMDAR signaling, CREB function and neuronal activity in the spinal 
cord differentially affect detour circuits following injury?  
2. Do these perturbations affect adult uninjured circuits and mature detour circuits, or is there a 
time sensitive window during which they exert their effects?  
3. Do differences in levels of neuronal activity of cervical neurons impact target selection of 
remodeling CST fibers? 
4. Is neuronal activity in the cervical spinal cord crucial for behavioral recovery following SCI? 
We hypothesized that downregulating neuronal activity dependent processes in the mouse 
cervical spinal cord during remodeling affects the CST detour circuit when compared to nonmanipulated 
mice. The next two chapters are dedicated to our methodological setup and results obtained whilst 




   
MATERIAL AND METHODS 
MOUSE STRAINS AND HUSBANDRY 
Mice used in this thesis included: C57Bl/6 wildtype mice (Charles River, strain code#475), Vglut2-
ires-cre (Jax#028863), 131 GlyT2-eGFP  132, and NR1flox (Jax#005246) 133  mice. Vglut2-ires-cre mice 
express cre recombinase in all glutamatergic neurons without affecting endogenous expression of 
vesicular glutamate transporter 2. NR1flox mice were used to create nonfunctional NMDAR by deleting 
the GluN1 subunit of the NMDAR when cre recombinase is expressed. GlyT2-eGFP express enhanced 
green fluorescent protein (eGFP) in all glycinergic cells without affecting endogenous expression of the 
glycine transporter 2.  
All mice were between six and twelve weeks old at the beginning of experiments. Female mice 
were used preferentially. Mice were assigned randomly to control or experimental condition prior to 
injury. Experiments with mice of different age and sex were split equally between conditions although 
we observed no discernable difference in outcome based on age/sex.  
If bred out of house, mice were given one week to adjust to the institution’s animal facility before 
the start of experiments. Mice had access to food and water ad libitum and were housed in a light/dark 
cycle (12:12h). Animal care, including monitoring of weight, pain, and behavioral impairments, was 
performed twice daily for two weeks after injury and, as needed, until sacrifice. All animal experiments 
followed regulations of the animal welfare act and protocols approved by the district government of 
Upper Bavaria. 
SURGICAL PROCEDURES 
Exact timing of surgeries and assignment of type of surgery to each animal model are illustrated 
in the experimental setup scheme of each experiment’s figure in the Results section. All surgeries were 
performed under full general anesthesia with a mixture of ketamin/xylazine (100 mg/kg ketamine and 
13 mg/kg xylazine). Before surgery, mice were orally administered 15µl of meloxicam (Metacam, 
Boehringer Ingelheim, 2mg/kg) and kept on heating pads, at body temperature, until fully anesthetized 
as tested by a hindlimb toe pinch test. After surgery, mice were kept on heating pads until fully awake. 
There, they had ad libitum access to water and food and, in case they were spinally hemisected, 
received a 1ml subcutaneous injection of saline. 12h post-surgery mice again received 15µl of 
meloxicam. Meloxicam could be topped up 24h post-surgery, if the experimenter judged the mouse to 
still be in pain, based on facial expressions, grooming, food/water intake, vocalization of the mouse.  
THORACIC DORSAL HEMISECTIONS 
The mice’ limbs were loosely pulled to the side with rubber bands. Incision into the skin at thoracic 
level was performed with a scalpel. Ribs and fat tissue aided in the identification of thoracic level 8 (T8). 
Incising into fat and muscle tissue exposed the T8 vertebra. A laminectomy was performed, and the 
Material and Methods 
26 
local anesthesia Lidocaine (Xylocaine 2% gel; AstraZeneca) was applied for 2min. With fine iridectomy 
scissors the spinal cord was dorsally hemisected, lesioning the major dorsomedial and minor 
dorsolateral CST, whilst leaving the minor ventromedial CST intact. Previously cut muscle tissue was 
sutured, and the skin was closed with wound clips.  
STEREOTACTIC INJECTIONS 
Injections were all performed with fine pulled glass micropipettes that were attached to syringes 
via cannulas. Micropipettes were slowly (0.1mm/min) lowered into the tissue using a stereotactic frame 
and remained at the final injection location for 1min before starting the injection. The tracer or AAV was 
injected slowly (~0.05µl/min) by applying weak syringe pressure to avoid tissue damage. After the 
injection was complete, the micropipette remained in place for another minute. Afterwards, it was 
extracted as slowly as it was inserted.   
SPINAL CORD INJECTIONS 
Mouse fixation, skin incision, and connective/muscle tissue removal were performed as described 
above. Cervical vertebrae were identified counting downward from cervical vertebra 1. Here, the dura 
was removed at injection site and AAV injected without a laminectomy. Where we injected twice 
cervically, we injected at cervical level 4 (C4; 0.5 µl AAV injected bilaterally, ±0.4mm lateral and -0.7mm 
depth). Where we injected four times to maximize expression in the behavioral and intersectional 
labeling experiments, we injected in an alternating pattern of right and left, spanning the spinal cord from 
C4 to C6 (2x0.5 µl AAV injected bilaterally; ±0.4mm lateral and -0.8mm depth).  
Lumbar vertebrae were identified using ribs; the most caudal rib attaches to thoracic vertebra 13, 
lumbar vertebra 1 is caudal to this. Due to the small intervertebral space, a laminectomy was performed 
to expose the spinal cord at lumbar level 1. 0.5µl AAV/Fluorogold (1% in 0.1M Cacodylate buffer, 
Fluorochrome) were injected bilaterally at ±0.3mm distance to the midline and -0.6mm depth. After 
spinal cord injections, mice were closed up as described above.  
BRAIN INJECTIONS 
For brain injections, the mouse head was fixed in a stereotactic frame. The skin was incised with 
a scalpel roughly above the motor cortex. Using bregma, injection coordinates were determined on top 
of the skull, and holes in the bone were created with a dental drill. 1µl BDA (10000MW, Life technologies, 
dissolved in 0.1M phosphate buffer) was injected bilaterally (hindlimb motor cortex coordinates from 
bregma: −1.3mm caudal, ±1.2mm lateral, and -0.6mm depth; forelimb motor cortex coordinates from 
bregma: −0.6mm caudal, ±1mm lateral, and -0.6mm depth). The skin was closed with wound clips.  
NEURONAL ACTIVITY MANIPULATION 
Exact timing of manipulations and assignment of specific AAV to each animal model are illustrated 
in the experimental setup scheme of each experiment’s figure in the Results section.  
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AAV TOOLS 
The control pAAV-CMV-GFP was created by inserting an eGFP sequence from pEGFP-N1 
(Clontech) into the HincII site of pAAV-CMV-MCS (Stratagene). For pAAV-CMV-GFP-Ires2-Cre the 
following sequences were inserted additionally, upstream of GFP in the order of: cre sequence from 
Cre-recombinase expression vector pBS185 (gift from Thomas Hughes, Montana State University), ires 
sequence from pIres2-DsRed2 (BD Bioscience). pAAV-CMV-eGFP-T2A-aCREB was gifted from H. 
Gainer (National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, 
MD). pAAV-hSyn-DIO-hM4D(Gi)-mCherry was a gift from B. Roth (University of North Carolina, Chapel 
Hill, Chapel Hill, NC). 
 We followed standard procedure to generate AAVs with the aforementioned plasmids at a 1:1 
ratio of AAV1 and AAV2 capsid proteins. All remaining AAVs used were purchased from addgene: 
AAV2-hSyn-DIO-hM4Di(Gi)-mCherry (catalog#44362-AAV2), AAV8-hSyn-DIO-hM4Di(Gi)-mCherry 
(catalog#44362-AAV8), and AAV2-pmSyn1-eBFP-cre (catalog#51507-AAVrg). All AAV plasmids are 
allocated to the respective experiments in Table 1. All genomic titers exceeded 1x10e10.  
PHARMACOLOGICAL MANIPULATION 
To block NMDAR pharmacologically, animals received a daily i.p. 
injection of MK801 (0.25mg/kg in saline, Tocris Bioscience). The dose 
was based on a previous, developmental study. 134 We ruled out that a 
reduction in anatomical remodeling was indirectly caused by a decline 
in locomotor activity due to MK801 administration. The movement of 
mice after MK801 injection was tracked in an open field for up to 3h. 
MK801 did not induce sedation but a transient increase in locomotor 
activity (Figure 8).  
To stimulate DREADDs, the hM4Di receptor specifically, and 
decrease neuronal activity, we administered subcutaneous clozapine-N-
oxide (CNO; 1mg/kg diluted in saline, Sigma-Aldrich) every 12h. Before 
behavioral testing, animals were not treated with CNO for 24h to ensure 
Manipulation Figure Plasmid Promoter 
NR1 
experiment 
13C-F, 19A-B pAAV-CMV-eGFP CMV pAAV-CMV-eGFP-IRES-Cre CMV 
15 pAAV-CMV-eGFP CMV pAAV-CMV-eGFP-IRES-Cre CMV 
CREB 
experiment 
14, 19C-9 pAAV-CMV-eGFP CMV pAAV-CMV-eGFP-T2A-aCREB CMV 
16 pAAV-CMV-eGFP CMV pAAV-CMV-eGFP-T2A-aCREB CMV 
Global 





17E-M, 19E (bottom), 19F (right) pAAV-hSyn-DIO-hM4D(Gi)-mCherry hSyn 





TABLE 1 AAV plasmids used in respective experiments of this dissertation. 
 
FIGURE 8 MK801 injection does not 
lead to movement decline. Distance 
traveled after 0.25mg/kg MK801 or 
saline injection in an open field 
setup. Each time point was 
measured in 30min intervals. Bar 
lengths represent means, and error 
bars represent SEMs. One 
independent experiment (n = 4 mice 
per experimental setting). 
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that observations were based on chronic anatomic changes and not on 
transient silencing of neurons. We did not observe significant behavioral 
effects from chronic CNO administration alone (Figure 9). Instead of 
MK801 and CNO, controls received saline with the same respective 
administration scheme as described above.  
TISSUE PROCESSING 
TRANSCARDIAL PERFUSION 
Mice were sacrificed by isoflurane overdose (AbbVie, North 
Chicago, US) and perfused intracardially with 4% paraformaldehyde in 
phosphate buffered saline (PBS). After extracting skull and vertebral 
column from the mouse body, the tissue was stored in the perfusion 
solution for 24h. Tissue was rinsed in PBS before microdissecting, i.e. 
removing the intact spinal cord and brain from vertebrae and skull. 
Spinal cord and brain were, then, transferred to 30% sucrose in PBS for 
48h cryoprotection. 
CUTTING 
Freezing the tissue in optimal cutting temperature medium (Tissue-Tek, Sakura, Finetek, USA) 
for at least 20min prepared it for cryostat (Leica CM1850) cutting. We cut 50µm coronal sections of the 
cervical enlargement and brain containing motor cortex as well as sagittal sections of the lesioned 
thoracic spinal cord. The cervical spinal cord was cut free-floating and only mounted after staining, 
creating a random order of sections. After cutting the thoracic spinal cord and brain sections, they were 
directly and sequentially mounted on slides coated in 0.5% gelatin and 0.05% chromium potassium 
sulfate.  
STAINING 
To amplify the BDA signal, sections were incubated with the ABC Complex (Vector Laboratories) 
overnight at 4°C. After a tyramide amplification (Biotin-XX, TSA Kit 21, Life Technologies) for 30min, 
sections were incubated in streptavidin-conjugated Alexa Fluor 647 (1:500 in PBS, Life Technologies) 
or streptavidin-conjugated Alexa Fluor 594 (1:500 in PBS, Life Technologies) overnight. 
AAV induced expression was amplified with immunohistochemistry when the virus was only 
expressed for seven days. AAVs with mCherry yielded dotty labeling. Hence, NeuN staining was 
performed to determine the boundaries of the infected neurons. Synapsin-I staining aided in the 
characterization of bouton maturity (explained in “Image Acquisition, Processing and Analysis”). Before 
applying antibodies, all sections were treated with a blocking solution (10% goat serum/0.1% 
TritonX/PBS) for 1h at room temperature. All subsequent antibody stainings are summarized in Table 
2. All samples were coverslipped with Vectashield (Vector Laboratories).  
FIGURE 9 Chronic CNO 
administration alone does not lead to 
chronic behavioral effects. Mice were 
lesioned and, starting at 14dpi, 
treated with twice daily injections of 
CNO (1mg/kg, orange) or saline 
(black) until 21dpi. One day after the 
last injection locomotion was tested 
using CatWalk. No differences after 
PCA on CatWalk parameters could 
be seen between the saline-treated 
and the CNO-treated group. Small 
dots represent each mouse, big dots 
represent the mean of each group. 
One independent experiment (n = 
7-8 mice per experimental setting). 
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IMAGE ACQUISITION, PROCESSING, AND ANALYSIS 
For figures of this thesis, images of boutons (20x objective, 1024 × 1024 pixels, zoom x1.1, 
0.45µm z-resolution, Kalman integration: 2), and the overview image of LPSN infection (20x objective, 
1024 x 1024 pixels, zoom x1, 0.45µm z-resolution) were scanned at high resolution with an Olympus 
FV1000 confocal microscope. The LPSN overview image was stitched in Fiji with the plugin 
“Grid/Collection”. To reduce background fluorescence from lipofuscin and spectral overlap in the AAV 
channel, we subtracted the BDA channel from it. For illustration purposes, some images were subjected 
to gamma adjustments in Fiji or Adobe Photoshop.  
Acquisition settings for illustration purposes and analysis of all images were the same for the 
experimental and control group of one experiment. The experimenter was blinded for image analyses 
concerning experimental and control group.   
 
LESION VOLUME 
Neurotrace stained sections with lesion were scanned using an 
Olympus IX71 fluorescence microscope (5x objective, 1376x1032, 
zoom x1). Resulting 2D images were processed with ImageJ, and the 
lesion area was identified based on the integrity of neurotrace stained 
neurons. Both, the cavity and surrounding damaged tissue, was outlined 
(Figure 10A). To quantify the lesion volume, the measured lesion area 
of each section was multiplied by the section thickness (50μm), and the 
results of consecutive sections were summed for each animal to provide 
a final estimation of the total lesion volume. No significant difference 
between experimental and control groups could be detected (Figure 
10B), illustrating the reproducibility of dorsal hemisections induced by 




Primary Antibody Incubation Secondary Antibody Incubation 
rabbit anti-GFP (1:500, A11122, 
Life Technologies) 4°C, overnight 
goat anti-rabbit-488 (1:500, 
A11008, Life Technologies) 4°C, overnight 
rabbit anti-Synapsin-I (1:500, 
AB1543, Millipore) 4°C, 24h 
donkey anti-rabbit-DyLight 405 




mouse anti-NeuN antibody (1:500, 
MAB377, Millipore) 4°C, overnight 
goat anti-mouse-488 (1:500, 
A11001, Life Technologies) 4°C, overnight 
TABLE 2 Protocols for immunohistochemical staining used in this dissertation. 
 
FIGURE 10 Mice received 
reproducible thoracic dorsal 
hemisections. (A) Sagittal section at 
T8 of example lesion, dotted line 
indicates lesion measurement in 
single images. (B) Lesion volumes of 
mice analyzed did not differ between 
control and experimental groups (p = 
0.1121). Data analyzed using 
student’s t test (two-tailed, unpaired). 
Bar lengths represent means, and 
error bars represent SEMs. Scale 
bar: 100µm. ns: not significant. Nine 
grouped independent experiments (n 
= 29-39 mice per experimental 
condition). 
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LOCALIZATION OF AAV+ NEURONS 
Low resolution images of 4 whole spinal cord 
sections per animal (Figure 11) were acquired with 
an upright Leica DM4 fluorescence microscope (5x 
objective, 1392x1040 pixels, zoom x1). Images 
were registered on an Adobe photoshop template 
so that all sections were oriented the same with the 
central canal in the same position. For illustration 
purposes, the coordinates of registered neurons were then extracted from Fiji and used to create 
topographic maps in Python, which in turn were placed on a spinal cord template from a mouse spinal 
cord atlas. 12 
RULING OUT UNDESIREABLE RETROGRADE AAV INFECTION  
To ensure that AAV manipulation only occurred in the spinal cord and did not affect CST fibers 
by undesirable retrograde transport of the virus, we analyzed the motor cortex for any AAV-induced 
fluorophore positivity. At least three brains (from 300µm rostral to 300µm caudal of BDA injection site) 
per experimental group were checked under an Olympus IX71 fluorescent microscope and no AAV 
positive cells could be detected.  
CST FIBERS 
To control for differences in BDA labeling, all quantifications involving the CST were normalized 
to the number of BDA-labeled fibers quantified in the dorsomedial CST. CST labeling inside the dorsal 
column of the cervical tract was relatively uniform, so that an analysis of 3-5 sections in this area was 
representative of BDA labeling in the entire animal. Per animal, the first 6µm of at least 3 random dorsal 
columns were scanned (Figure 11) using an Olympus FV1000 confocal microscope (20x objective, 640 
× 640 pixels, zoom x1.1, 0.45µm z-resolution). Images where long CST collaterals crossed the tract 
were excluded from the analysis. Images were analyzed in an automated fashion: The “Analyze 
Tubeness” Fiji plugin was applied to the tract. The number of fibers were, then, quantified using the “3D 
Object Counter” plugin.  
EXITING CST COLLATERALS 
Exiting collaterals were quantified on images (Figure 11) of at least 30 sections taken with an 
Olympus FV1000 confocal microscope (20x objective, 640 × 640 pixels, zoom x1.1, 0.45µm z-
resolution) in Imaris. In case of hindlimb CST tracing the entire depth of the dorsal column in a section 
was analyzed. Where forelimb CST fibers were traced, labeling was so dense that only the upper 5µm 
of each section were quantified. In Imaris, in 3D “blend mode”, all collaterals clearly crossing the 
gray/white matter boarder were manually counted. The total number of exiting collaterals per animal 
was normalized to the respective number of BDA labeled CST fibers. 
 
FIGURE 11 Different fields of view for analyses on sections of 
the cervical enlargement. Scale bar: 100µm. 
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MAIN GRAY MATTER ANALYSES 
Per animal, at least 20 sections were scanned using an Olympus FV1000 confocal microscope 
(20x objective, 640×640pixels, zoom x1.1, 0.45µm z-resolution). Instead of scanning and stitching entire 
sections, one image was acquired left and right of the spinal cord midline. Image field of views were 
positioned with the midline and central canal as reference points – the midline aligned with the right or 
left edge of the image, and the central canal is positioned one third from the top (Figure 11). This position 
allowed for two separate images covering the vast majority of gray matter where CST sprouting 
occurred. Few images from animals with injections of AAVs with a CMV promoter, were excluded from 
the analysis if glial cells were labeled as assessed by their different morphology as opposed to neurons. 
In the following, all analyses on the described images will be outlined.   
CST COLLATERAL LENGTH 
On converted 8bit, maximum intensity z projections, collaterals were traced semi-automatically 
using the “NeuronJ” Fiji plugin. Length of all collaterals was summed up per section and normalized to 
the respective number of BDA labeled CST fibers.  
CST BOUTON DENSITY 
On maximum z projections, experimenters were trained to 
recognize boutons on CST collaterals based on size and brightness in 
relation to immediately adjacent collaterals. More precisely, the bouton’s 
maximum Ferret diameter needed to be ~2x bigger and its maximum 
intensity ~3x brighter. Bouton density was, then, calculated by dividing 
bouton number by collateral length per image.  
In a subset of recognized boutons (n = 122), we confirmed that 
experimenters adhered to the aforementioned criteria. Furthermore, we 
consider the majority of identified boutons as mature since they already 
express presynaptic machinery attested by synapsin-I staining. In 
rescanned high-resolution images with a Leica TCS SP8 confocal 
microscope (63x objective, 788x788pixels, zoom x1, 0.3µm z-
resolution), above 70% of boutons were considered synapsin-I positive 
(Figure 12).  
TOTAL AAV+ NEURONS 
To control for differences in AAV expression, all quantifications involving AAV infected neurons 
were normalized to the number of these cells. For this purpose, number of AAV positive cells were 
counted manually on maximum intensity projections.  
CONTACTED AAV+ NEURONS 
It was sufficient to analyze 10 of the scanned sections per animal for contacted AAV positive 
neurons. In case of hindlimb CST labeling, the entire image stack was assessed, and for dense forelimb 
FIGURE 12 The majority of identified 
boutons are synapsin-I positive. (A) 
Example bouton with synapsin-I 
staining. Left: confocal maximum 
projection of BDA labeled CST 
collateral, right: single plane 
synapsin-I staining at center of 
bouton. Dotted line indicates bouton 
border. (B) Quantification of 
synapsin-I staining in more than 80 
boutons. Bar length represents 
mean, and error bar represents 
SEM. Scale bar: 2µm. One 
independent experiment (n = 6 
mice). 
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CST labeling only 5µm of each section were analyzed. AAV positive contacted neurons were analyzed 
in 3D “blend mode” in Imaris. For AAV-mCherrys, contacts were analyzed on NeuN stained neurons 
and later checked for AAV positivity (described below). For AAV-GFPs, a median filter was applied to 
the GFP channel to bring cell bodies and proximal rather than distal dendrites infected to the foreground. 
This reduced the complexity of an image and allowed us to assign dendritic contacts to a specific neuron.  
If the following criteria were met, contacted cells were counted: (1) due to point spread of confocal 
images, a CST collateral needed to clearly overlap with the cell body or a proximal dendrite, (2) 
collaterals exhibited a bouton (meeting additional criteria as described above) where they touched the 
AAV infected cell. In Imaris, contacted neurons were marked with the “measurement points” tool. The 
total number of contacted cells per section was normalized to the respective number of BDA labeled 
CST fibers of an animal and the number of AAV infected neurons of the same section.  
To verify our approach of analyzing contacted neurons, we rescanned a subset of them (n = 137 
of 7 animals) at high resolution using an Olympus FV1000 confocal microscope (20x objective, 
1024x1024pixels, zoom x7.7, 0.15µm z-resolution) and reanalyzed them on single planes in Fiji. All of 
the contacted cells recognized with lower resolution in 3D were reidentified as contacts in 2D high 
resolution images.  
BOUTON DENSITY OF CONTACTING CST COLLATERALS 
In one experiment we not only measured the number of contacted AAV neurons but also how 
many boutons were in close apposition with one contacted neuron. In addition, we normalized the 
number of boutons to a measured length of a stretch of CST collateral that clearly overlapped with an 
AAV infected cell, yielding a measurement of bouton density of collaterals contacting AAV positive 
neurons.  
CONTACTED LPSN DENDRITES AND SOMA 
In our sparsely labeled LPSN experiment, we could investigate whether manipulation would affect 
contacts onto somata and proximal or distal dendrites differentially. This analysis was performed in Fiji 
where potential contacts were first identified on maximum projections and afterwards confirmed or 
refuted on single planes using the same criteria as described above.  
AAV-MCHERRY INTENSITY  
DREADD receptor coupled mCherry intensity inside NeuN positive neurons was determined in 
Imaris. The surfaces of NeuN neurons were rendered using the “Marching cubes” setting in the Imaris 
“Surface” tool. Mean mCherry intensities per analyzed neuron were extracted. Background mean 
intensity was measured in selected regions of interest devoid of AAV positive structures on five average-
intensity projections per mouse in Fiji. Averaged gray matter background mCherry intensity was 
subtracted from neuronal mCherry intensities. If the neuronal intensity was higher than the mean 
background intensity, the NeuN cell was considered mCherry positive.  
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MOTOR SKILL ANALYSIS 
Motor skills were assessed with a CatWalk XT (Noldus) system. The pre-injury mice were 
habituated to the setup three times, one week prior to the first recording. At each time point, three 
successful runs were recorded per mouse that followed the preset requirements, based on 
recommendations by the manufacturer: (1) minimum run duration of 0.5s, (2) maximum run duration of 
4s, (3) maximum speed variation of 60%. These requirements guaranteed a low variance in between 
runs. All runs were, thus, comparable, and the different parameters could be analyzed across mice and 
treatment groups. As in previous studies, recordings always took place one day after the last CNO/saline 
injection. 135 This setup ensured that short-term CNO or its metabolized form would not affect the mice’ 
behavior by actively silencing DREADD infected cells. All behavioral changes observed could, thus, be 
explained by anatomic long-term alterations.   
CatWalk generated 177 parameters. To interpret the data, we performed a PCA with the online 
tool ClustVis (row scaling: “unit variance scaling”, PCA method: “SVD with imputation”) 136 on the 21dpi 
data, as this was our time point of interest. We applied the generated 21dpi parameter loadings and the 
unit variance scaling to the other time points to calculate each mouse’ value for principal component 
(PC) 1 and 2.  We used the pre-injury PC1 of each mouse as a baseline and subtracted it from PC1 
values at other time points to reduce between mice variance not explained by CNO treatment (Figure 
18D). To show that chronic CNO administration alone does not alter locomotion after SCI we repeated 
the same motor skill analysis (Figure 9). 
MK801 motoric data to exclude the possibility of sedative effects of the drug (Figure 8) were 
generated in an open field. The mice’ movement was tracked in 30min intervals using the automated 
tracking software ANY-maze (v. 4.99). To reduce stress in animals, 0-90min and 120-210min were 
tested on different days.  
STATISTICS 
For ease of illustration and to combine sets of experiments acquired at different time points, data 
sets are expressed as percentages of controls. All statistical evaluations were performed in GraphPad 
Prism (v. 7.00). Normality was tested using D’Agostino-Pearson omnibus normality test. When data 
were normally distributed, control and experimental groups were compared using an unpaired, two-
tailed student’s t test and data were normalized to the control mean. Results are, then, reported as mean 
± SEM. When data did not pass the normality test, control and experimental groups were compared 
using Mann-Whitney (Figure 17K right, Figure 17M right) or Kolmogorov-Smirnov test (Figure 17K left), 
and data were normalized to the control median. The medians of data analyzed with a Mann-Whitney 
test are presented in box-and-whisker plots, where box borders represent the 25th and 75th percentile 
and whiskers the 10th and 90th percentile. Data analyzed with a Kolmogorov-Smirnov test are presented 
in cumulative frequency graphs with the upper limit set to 100% of the experimental group. Behavioral 
data with multiple time points (Figure 18D) were evaluated with a repeated two-way ANOVA.  Primary 
measure showed statistical significance and was, thus, followed by a Bonferroni post hoc t-test. 
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Statistical outliers were determined with the robust regression and outlier test (Q = 1). Only four animals 
were detected and excluded from all analyses. Significance level is defined as follows: *p < 0.05, **p < 




   
RESULTS 
MANIPULATING NMDAR FUNCTION ALTERS CST REMODELING 
To first probe our hypothesis of neuronal activity playing a role in CST remodeling after SCI, we 
pharmacologically inhibited NMDARs with the antagonist MK801. In unmodified, spontaneous 
remodeling three weeks after a thoracic dorsal hemisection, rodent CST fibers will have sprouted 
extensively in the cervical enlargement to contact PSNs. 126 We, thus, examined the effects repeated 
MK801 injections would have during detour circuit establishment (2-3weeks after injury) on the 
remodeling of CST collaterals in the cervical enlargement (Figure 13A). We quantified en passant 
boutons on BDA labeled CST collaterals in confocal images of the cervical spinal cord. Boutons 
represent presynaptic swellings that typically contain synaptic vesicles and an active zone. 137 The 
number of boutons was normalized to CST collateral length, to ensure that a change in bouton number 
did not result from a mere reduction in collateral length. Pharmacologically blocking NMDARs with 
MK801 led to a significant decrease in bouton density of CST collaterals when compared to control mice 
treated with saline (Figure 13B).   
An antagonist like MK801 binds to all NMDARs in the murine CNS. Thus, the observed reduction 
in bouton density could be explained by NMDAR blocking in the cortex as the origin of the remodeling 
CST itself, by NDMAR blocking in spinal target neurons of the remodeling CST, or by other off-target 
effects. To restrict NMDAR manipulation to the location of CST sprouting plus contact formation onto 
PSNs, we performed spinal cord anterograde AAV injections at C4 of an NR1 floxed mouse line (Figure 
13C). In this mouse line, the sequence for NR1, a subunit of the NMDAR, is flanked by lox sites. Upon 
expression of cre, induced by an AAV-GFP-cre injection, the NR1 sequence is excised, rendering the 
receptor nonfunctional in cervical neurons. Control mice received C4 injections with an AAV lacking the 
cre sequence. Adjusting the titers of both AAVs led to similar GFP expression in terms of the number of 
infected cells (AAV-GFP-Cre: 147 ± 13 GFP positive neurons/section, AAV-GFP: 167 ± 8 GFP positive 
neurons/section; n = 6-8 mice per group) and their localization (Figure 19B). 
Similar to pharmacological blocking of NMDARs, this manipulation during detour circuit 
development led to a decrease in bouton density along sprouting CST collaterals (Figure 13E). While 
boutons have long been accepted to functionally connect neurons, they merely represent the 
presynaptic structure. Thus, bouton analysis alone does not explain which spinal neurons are contacted 
less. We extended our analysis to assess whether these presynaptic CST boutons are less likely to 
contact NMDAR manipulated neurons, tagged with GFP. In fact, knocking out NMDAR during detour 
circuit establishment significantly decreased the number of contacted GFP positive neurons in 
comparison to control, NMDAR competent, mice (Figure 13D). NMDAR function, thus, appears to be 
crucial in the formation of contacts between motor tract collaterals and relay neurons of detour circuits. 
Other than synaptic impairments, general CST collateral anatomy in the cervical cord, such as the total 
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collateral length in the gray matter or the number of collaterals exiting the white matter tract to enter 




MANIPULATING CREB FUNCTION ALTERS CST REMODELING  
To investigate whether pathways downstream of NMDAR signaling play a role in CST remodeling 
after SCI, we inhibited the activity dependent transcription factor CREB. For this purpose, we made use 
of aCREB, a mutated version of CREB, which prevents binding of endogenous CREB to the DNA. For 
the experimental condition, we injected an anterograde AAV-GFP-aCREB into C4 of wildtype C57Bl6 
mice and compared their CST remodeling to control mice with mere anterograde AAV-GFP injections 
(Figure 14A). Both AAVs exhibited similar spinal cord infection, quantified by the number of infected 
cells (AAV-GFP-aCREB: 159 ± 8 GFP positive neurons/section, AAV-GFP: 148 ± 8 GFP positive 
neurons/section; n = 6-8 mice per group) and their location (Figure 19D).  
Similar to NMDAR manipulation, inhibiting CREB during detour circuit formation resulted in a 
decrease in the number of manipulated spinal neurons contacted by CST collateral boutons (Figure 
14B). The most prominent change occurred in CST collaterals themselves. CREB inhibition after SCI 
FIGURE 13 Manipulating NMDAR function alters CST 
remodeling. (A) Experimental setup for pharmacological 
inhibition of NMDARs during detour circuit formation after a 
thoracic dorsal hemisection. (B) Left: confocal maximum 
projection of exemplary CST collaterals in the cervical gray 
matter with bouton quantification indicated with arrows. Right: 
quantification of bouton density (number of boutons per 
collateral length) along CST collaterals in NMDAR inhibited 
(MK801) versus non-inhibited mice (Saline; p = 0.0113). (C) 
Experimental setup for genetically inhibiting NMDAR function 
in cervical neurons during detour circuit formation after a 
thoracic dorsal hemisection. (D) Left: 3D reconstruction of an 
example confocal image showing the analysis of contacted 
GFP+ neurons. A contact is indicated with an arrow, which 
identifies the GFP+ neuron as contacted. Right: quantification 
of the number of contacted GFP+ neurons in mice with NMDAR 
functioning (-cre) versus nonfunctioning (+cre) cervical 
neurons (p = 0.0168). Values are normalized to the number of 
GFP+ neurons and CST labeling (assessed by number of BDA 
labeled CST white matter fibers). (E) Left: confocal maximum 
projection of exemplary CST collaterals in the cervical gray 
matter with bouton quantification indicated with arrows. Right: 
quantification of bouton density along cervical CST collaterals 
(p = 0.0064) (F) Left: quantification of the number of cervical 
CST collaterals exiting the white matter to enter the gray matter 
(p = 0.2584). Right: quantification of the total length of all CST 
collaterals in the cervical gray matter (p = 0.9673). Values are 
normalized to CST labeling. Data analyzed using student’s t 
test (two-tailed, unpaired). Bar lengths represent means, and 
error bars represent SEMs. *p < 0.05, **p < 0.01. Scale bars, 
10µm in (B), (D), and (E). Ctrl: control. ns: not significant. (B) 
one experiment (n = 6-9 mice per group) with experimental 
setup shown in (A); (D)–(F) two grouped independent 
experiments (n = 6-8 mice per experimental condition) with 
experimental setup shown in (C). Figure adapted, with 




caused a decrease in the number of CST collaterals entering the cervical gray matter (Figure 14D and 
19C) and in their total length (Figure 14E). Innervation of the cervical gray matter was, thus, significantly 
sparser. These shorter CST collaterals did not exhibit a reduction in bouton density (Figure 14C).  
 
MANIPULATING ACTIVITY DEPENDENT PROCESSES IN MATURE 
CIRCUITS DOES NOT ALTER CST ANATOMY 
To test whether manipulating activity dependent processes impacts mature circuits, we 
genetically perturbed NMDAR function after a functioning detour circuit had already been established, 
i.e. 12 weeks after SCI (Figure 15A). Contrary to manipulating NMDAR function during detour circuit 
establishment, a delayed manipulation of spinal neurons did not affect CST anatomy in the cervical 
spinal cord. More specifically, the number of GFP positive contacted neurons (Figure 15B), bouton 
density along CST collaterals (Figure 15C), CST collateral length, and the number of exiting CST 
collaterals (Figure 15D) were unaltered.  
FIGURE 14 Manipulating CREB function alters CST 
remodeling. (A) Experimental setup for genetically inhibiting 
the activity dependent transcription factor CREB during detour 
circuit formation in cervical neurons after a thoracic dorsal 
hemisection. (B) Left: 3D reconstruction of an example 
confocal image showing the analysis of contacted GFP+ 
neurons. A contact is indicated with an arrow, which identifies 
the GFP+ neuron as contacted. Right: quantification of the 
number of contacted GFP+ neurons in mice with CREB 
operational (-aCREB) versus inhibited (+aCREB) cervical 
neurons (p = 0.0393). Values are normalized to the number of 
GFP+ neurons and CST labeling. (C) Left: confocal maximum 
projection of exemplary CST collaterals in the cervical gray 
matter with bouton quantification indicated with arrows. Right: 
quantification of bouton density along cervical CST collaterals 
(p = 0.1636). (D) Quantification of the number of cervical CST 
collaterals exiting the white matter to enter the gray matter (p = 
0.0229). Values are normalized to CST labeling. (E) Left: 
confocal maximum projection of exemplary cervical gray matter 
area where CST sprouting occurs. Arrows indicate collaterals. 
Dotted line indicates white matter border. Right: quantification 
of the total length of all CST collaterals in the cervical gray 
matter (p = 0.0004). Values are normalized to CST labeling. 
Data analyzed using student’s t test (two-tailed, unpaired. Bar 
lengths represent means, and error bars represent SEMs. *p < 
0.05, ***p < 0.001. Scale bars, 10µm in (B) and (C); 50µm in 
(E). Ctrl: control. ns: not significant. Two grouped independent 
experiments (n = 6-8 mice per experimental condition) with 
experimental setup shown in (A). Figure adapted, with 





To answer whether CREB could influence mature, intact neural circuits, we genetically inhibited 
the transcription factor as described above, but without a lesion and with a traced forelimb rather than 
hindlimb CST (Figure 16A).  In the mature and intact CNS, forelimb CST fibers have numerous 
connections with spinal neurons in the cervical cord to generate movement of the forelimbs. 
Manipulating CREB in these spinal neurons did not induce any detectable anatomic alterations. Forelimb 
CST collateral boutons contacted a similar number of CREB deficient and competent (GFP positive) 
neurons in the cervical cord of control and experimental mice (Figure 16B). Its CST collateral 
morphology was unaltered in terms of bouton density (Figure 16C), number of exiting collaterals (Figure 
16D) and total collateral length (Figure 16E). Manipulating NMDAR and CREB function by itself, thus, 
does not alter anatomic circuits, but its effects are specific to phases of detour circuit formation.  
FIGURE 16 Manipulating CREB function in a mature circuit 
does not alter CST anatomy. (A) Experimental setup for 
genetically inhibiting the activity dependent transcription factor 
CREB in cervical neurons that are contacted by forelimb CST 
fibers in a mature circuit. (B) Left: 3D reconstruction of an 
example confocal image showing the analysis of contacted 
GFP+ neurons. A contact is indicated with an arrow, which 
identifies the GFP+ neuron as contacted. Right: quantification 
of the number of contacted GFP+ neurons in mice with CREB 
operational (-aCREB) versus inhibited (+aCREB) cervical 
neurons (p = 0.7186). Values are normalized to the number of 
GFP+ neurons and CST labeling. (C) Left: confocal maximum 
projection of exemplary forelimb CST collaterals in the cervical 
gray matter with bouton quantification indicated with arrows. 
Right: quantification of bouton density along cervical forelimb 
CST collaterals (p = 0.7830). (D) Quantification of the number 
of cervical forelimb CST collaterals exiting the white matter to 
enter the gray matter (p = 0.2764). Values are normalized to 
CST labeling. (E) Left: confocal maximum projection of 
exemplary cervical gray matter area where forelimb CST 
collaterals project to. Arrows indicate collaterals. Dotted line 
indicates white matter border. Right: quantification of the total 
length of all forelimb CST collaterals in the cervical gray matter 
(p = 0.7713). Values are normalized to forelimb CST labeling. 
Data analyzed using student’s t test (two-tailed, unpaired). Bar 
lengths represent means, and error bars represent SEMs. 
Scale bars, 10µm in (B) and (C); 50µm in (E). Ctrl: control. ns: 
not significant. Two grouped independent experiments (n = 7-8 
mice per experimental condition) with experimental setup 
shown in (A). Figure adapted, with permission from ref. 130. 
  
 
FIGURE 15 Manipulating NMDAR function in a mature detour circuit does not alter CST remodeling. (A) Experimental setup for 
pharmacological inhibition of NMDARs in cervical neurons after detour circuit formation following a thoracic dorsal hemisection. 
(B) Left: 3D reconstruction of an example confocal image showing the analysis of contacted GFP+ neurons. A contact is indicated 
with an arrow, which identifies the GFP+ neuron as contacted. Right: quantification of the number of contacted GFP+ neurons in 
mice with NMDAR functioning (-cre) versus nonfunctioning (+cre) cervical neurons (p = 0.7564). Values are normalized to the 
number of GFP+ neurons and CST labeling. (C) Left: confocal maximum projection of exemplary CST collaterals in the cervical 
gray matter with bouton quantification indicated with arrows. Right: quantification of bouton density along cervical CST collaterals 
(p = 0.6397). (D) Left: quantification of the number of cervical CST collaterals exiting the white matter to enter the gray matter (p 
= 0.5023). Right: quantification of the total length of all CST collaterals in the cervical gray matter (p = 0.4458). Values are 
normalized to CST labeling. Data analyzed using student’s t test (two-tailed, unpaired). Bar lengths represent means, and error 
bars represent SEMs. Scale bars, 10µm in (B) and (C). Ctrl: control. ns: not significant. One experiment (n = 5-6 mice per 





GLOBALLY SILENCING SPINAL NEURON ACTIVITY DOES NOT ALTER 
CST REMODELING 
Next, we investigated whether suppressing neuronal activity in cervical spinal neurons directly 
affects CST remodeling. We chemogenetically silenced neurons via activating expressed hM4Di 
receptors, inhibitory DREADDs, in the cervical spinal cord. Like in all DREADDs, hM4Di expression itself 
does not suppress neuronal activity. Only when a synthetic ligand, in this case CNO, is administered to 
the mouse and binds to the receptor, will the neuron be silenced. Thus, the same AAVs can be used for 
control and experimental conditions. This chemogenetic tool allows for temporal, when CNO is 
administered, and reversible, when CNO is metabolized, neuronal silencing.  
hM4Di expression was induced by the injection of a mix of an anterograde AAV-DIO-hM4Di-
mCherry and anterograde AAV-GFP-cre into the cervical spinal cord of C57Bl6 wildtype mice (Figure 
17A). When neurons are infected with both AAVs, cre recombinase induced by AAV-GFP-cre will bind 
to the lox sites sequences of the other virus and result in the inversion of the flipped hM4Di-mCherry 
sequence. This intersectional targeting will lead to a successful expression of hM4Di, GFP, and 
mCherry. Since the same viruses were used for experimental and control animals they exhibited similar 
amounts of AAV infected neurons (-CNO: 119 ± 8 GFP positive neurons/section, +CNO: 119 ± 12 GFP 
positive neurons/section; n = 9 mice per group) and AAV expression patterns in the cervical cord (Figure 
19F). Mice of different groups did, however, differ in drug administration; experimental mice received 
chronic, twice daily, CNO injections during the detour circuit formation phase (14dpi to 21dpi), whilst 
control animals received saline injections.  
Surprisingly, global silencing of spinal neurons did not affect CST remodeling in all features 
analyzed. Mice that received chronic CNO injections exhibited similar amounts of contacted cervical 
spinal neurons as mice with mere saline injections (Figure 17B). Further, CST collateral morphology in 
the cervical spinal cord was also unaffected, in terms of bouton density (Figure 17C), total collateral 
length (Figure 17D), and number of exiting collaterals (Figure 17D and 19E).  
 SELECTIVELY SILENCING GLUTAMATERGIC SPINAL NEURON 
ACTIVITY ALTERS CST REMODELING 
When globally silencing spinal neurons, we manipulated neurons irrespective of their involvement 
in CST detour circuit formation after SCI. To exclude neurons, not contained in the detour circuit, from 
the manipulation, we first investigated the population of neurons initially contacted by remodeling CST 
collaterals after a thoracic dorsal hemisection. For this purpose, we focused on two major neuronal 
populations of the cervical spinal cord, based on their neurotransmitter profile: excitatory, glutamatergic 
neurons and inhibitory, glycinergic neurons. To analyze CST contacts onto inhibitory spinal neurons we 
used a mouse line in which glycinergic neurons are labelled (GlyT2-GFP mice). Contacts onto 
glutamatergic spinal neurons were analyzed by cervically injecting an anterograde AAV, inducing cre 
dependent fluorescence, into a VGlut-cre mouse line, expressing cre in all glutamatergic cells. Our 
results show that three weeks after a thoracic dorsal hemisection, remodeling CST collaterals 
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preferentially contact excitatory, glutamatergic neurons in the cervical spinal cord. However, inhibitory, 
glycinergic neurons are barely contacted. (VGlut: 5.8 ± 1.47% of all cervical glutamatergic neurons 
contacted, GlyT2: 0.4 ± 0.06% of all cervical glycinergic neurons contacted; p = 0.0003, n = 12-15 mice 
per group). 
Incorporating these results, we next specifically targeted glutamatergic neurons spontaneously 
contacted by remodeling CST collaterals. Therefore, we injected the anterograde AAV-DIO-hM4Di-
mCherry into C4 of the VGlut-cre mouse line (Figure 17E). By using the same CNO administration 
scheme as described above, we, thus, silenced glutamatergic cervical spinal neurons chronically during 
the phase of detour circuit formation, after a thoracic dorsal hemisection. CNO administration did not 
affect AAV transduction, which was similar across control and experimental group (-CNO: 172 ± 9 
mCherry positive neurons/section; +CNO: 174 ± 8 mCherry positive neurons/section; n =10-12 mice per 
group; Figure 19F). Due to the heterogeneous somatic labeling of neurons with DREADD-mCherry we 
stained the cervical spinal cord sections for NeuN. We, then, performed contact analyses on all neurons, 
as stained by NeuN, and later checked for their DREADD-mCherry positivity.  
Specifically silencing cervical glutamatergic neurons during detour circuit formation resulted in a 
reduction in the number of manipulated neurons contacted by CST collaterals (Figure 17F). In addition, 
CST collaterals exhibited lower bouton density (Figure 17G), they were less numerous (Figure 17H and 
Figure 19E) and shorter in total (Figure 17I) when compared to controls with non-silenced cervical 
glutamatergic neurons. Thus, whilst globally silencing cervical neurons irrespective of their 
neurotransmitter identity during detour circuit formation does not affect CST remodeling after SCI, 
specifically silencing cervical glutamatergic neurons impaired CST remodeling in all aspects analyzed. 
These two sets of data highlight the differences between the effects of global and selective neuronal 
silencing on remodeling following SCI.  
To extend our analysis on the effects of glutamatergic neuron silencing, we examined the number 
of contacts along CST collateral stretches that are in immediate vicinity of a cervical neuron (Figure 
17J). Not only did the number of contacts per contacted neuron decrease by glutamatergic neuron 
silencing in the cervical cord (Figure 17J), but the contact density of a contacting collateral stretch was 
also reduced (Figure 17K). These data indicate that the already few silenced neurons that have CST 
collaterals in immediate vicinity, receive decreased synaptic input from the CST when compared to non-
silenced neurons.  
Next, we investigated if the degree of neuronal silencing of cervical glutamatergic neurons would 
gradually affect their likelihood of being contacted by remodeling CST collaterals. Alternatively, there 
could be a clear cutoff value in neuronal activity determining if a neuron would be contacted or not. After 
identifying all cervical neurons (NeuN positive) contacted by CST collaterals, we rendered their NeuN 
positive surfaces and measured their mCherry-hM4Di intensity inside the neuron, as an indicator for the 
degree of neuronal silencing (Figure 17L). The resulting quantification, in fact, shows that in mice treated 
with CNO, where DREADDs actively silenced cervical neurons, mCherry intensity within a neuron 
negatively correlates with the likelihood of that neuron being contacted (Figure 17M left). Remodeling 
CST collaterals even seemed to have partially compensated for the decrease in contacted neurons in 
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CNO treated mice by contacting more neurons that were mCherry negative when compared to control 
mice. Thus, the median mCherry intensity of contacted cervical neurons is significantly decreased in 
mice treated with CNO (Figure 17M right). When given a choice, remodeling CST collaterals will 
preferentially contact active rather than silent neurons. These results reinforce the idea that 
glutamatergic cervical neurons compete for input from remodeling CST collaterals after SCI by varying 
degrees of neuronal activity.   
To check if further subpopulations of cervical excitatory neurons respond differently to modulating 
neuronal activity, we labeled LPSN by injection of the retrograde tracer Fluorogold into the lumbar spinal 
cord.  As described in the introduction, after a thoracic hemisection the CST sprouts spontaneously to 
contact LPSN in the cervical cord, which provide a detour to denervated lumbar motoneurons.  Silencing 
glutamatergic cervical neurons irrespective of any further identity also decreased the number of 
contacted LPSN (54.8% of control; n = 5-7 mice per group), which compares to the level of contact 
reduction onto all glutamatergic neurons (34.3 ± 8.6% of control; Figure 17F). Further, we observed a 
comparable reduction of contacted cells when we separately analyzed excitatory neurons located in 
different laminae of the CST projection area (57.7% of control for neurons in laminae V, 43.2% of control 
for neurons in laminae VI and 45.4% of control for neurons in laminae VII-VIII; control; n = 10-12 mice 
per group). Hence, the rules of activity dependent competition for input from remodeling CST collaterals 
apply as a general rule to various subpopulations of cervical glutamatergic neurons.  
SILENCING A SPECIFIC NEURONAL SUBPOPULATION ALTERS CST 
REMODELING 
To target a specific detour circuit, we selectively silenced LPSN by simultaneously injecting a 
retrograde AAV-cre into their lumbar projection area and an anterograde AAV-DIO-hM4Di-mCherry into 
their cervical origin in wildtype C57Bl6 mice (Figure 17N). To maximize the proportion of LPSN silenced, 
we adjusted our experimental approach from the one applied for silencing glutamatergic neurons: AAV 
expression time was increased by injecting AAVs before injury and sacrificing more than five weeks 
after injury, we injected AAVs at four locations cervically (spanning C4 to C6), and mice received chronic 
CNO injections for more than three weeks.   
The AAV-DIO transfected the cervical spinal cords of experimental and control animals similarly 
(-CNO: 11.8 ± 0.6 mCherry positive neurons/section, +CNO: 12.5 ± 0.6 mCherry positive 
neurons/section; n = 7-8 mice per group) where mCherry positive LPSN cell bodies localized in the 
intermediate laminae (Figure 17O). Silencing LPSN chronically with CNO during detour circuit formation 
resulted in a decrease in total contacts between CST collaterals and mCherry-DREADD positive LPSN 
when compared to control mice (Figure 17P). This decrease consists of a change in contacts onto cell 
bodies as well as dendrites, indicating a change in general contact number but not contact distribution. 
Thus, silencing LPSN specifically during detour circuit formation also decreases their likelihood of 




FIGURE 17 Activity dependent competition shapes detour circuit formation. (A) Experimental setup for chemogenetically silencing 
excitatory and inhibitory cervical neurons during detour circuit formation after a thoracic dorsal hemisection in C57Bl6 mice. (B) 
Left: 3D reconstruction of an example confocal image showing the analysis of contacted GFP+ neurons. A contact is indicated 
with an arrow, which identifies the GFP+ neuron as contacted. Right: quantification of the number of contacted GFP+ neurons in 
mice with non-silenced (-CNO) versus silenced (+CNO) cervical neurons (p = 0.9079). Values are normalized to the number of 
GFP+ neurons and CST labeling. (C) Left: confocal maximum projection of exemplary CST collaterals in the cervical gray matter 
with bouton quantification indicated with arrows. Right: quantification of bouton density along cervical CST collaterals (p = 0.1651). 
(D) Left: quantification of the number of cervical CST collaterals exiting the white matter to enter the gray matter (p = 0.2682). 
Right: quantification of the total length of all CST collaterals in the cervical gray matter (p = 0.9980). Values are normalized to 





SELECTIVELY SILENCING GLUTAMATERGIC SPINAL NEURON 
ACTIVITY PREVENTS LOCOMOTOR RECOVERY 
Lastly, we investigated whether manipulating neuronal activity and, thus, altering detour circuits 
would also affect locomotion as assessed by CatWalk experiments. We performed CatWalk 
experiments on mice with silenced cervical glutamatergic neuronal activity as we quantified furthest 
reaching anatomic changes after this manipulation. To maximize the number of glutamatergic neurons 
silenced, we injected an anterograde AAV-DIO-hM4Di-mCherry at four locations of the cervical spinal 
cord as performed in the LPSN silencing experiment (Figure 18A). To evaluate all crucial locomotor 
changes we assessed locomotor abilities with CatWalk at three time points: four days before injury, 
immediately after injury (3dpi), and chronically after injury and CNO or saline treatment (21dpi). To 
ensure that locomotion at 21dpi was explained by long-term alterations to the detour circuit, we stopped 
drug administration 24h before the behavioral testing at 20dpi. This experimental setup allowed us to 
eliminate potential short-term effects of CNO induced silencing of cervical glutamatergic neurons or off 
target effects of the drug. 
after a thoracic dorsal hemisection in VGlut-cre mice. (F) Left: 3D reconstruction of an example confocal image showing the 
analysis of contacted mCherry+ neurons. Contacts were analyzed on NeuN stained neurons (arrow). Contacted NeuN+ neurons 
were then checked for mCherry positivity. Right: quantification of the number of contacted mCherry+ neurons in mice with non-
silenced (-CNO) versus silenced (+CNO) excitatory cervical neurons (p = 0.0049). Values are normalized to the number of 
mCherry+ neurons and CST labeling. (G) Left: confocal maximum projection of exemplary CST collaterals in the cervical gray 
matter with bouton quantification indicated with arrows. Right: quantification of bouton density along cervical CST collaterals (p = 
0.0022). (H) Quantification of the number of cervical CST collaterals exiting the white matter to enter the gray matter (p = 0.0323). 
Values are normalized to CST labeling. (I) Left: confocal maximum projection of exemplary cervical gray matter area where CST 
sprouting occurs. Arrows indicate collaterals. Dotted line indicates white matter border. Right: quantification of the total length of 
all CST collaterals in the cervical gray matter (p = 0.0044). Values are normalized to CST labeling. (J) 3D reconstruction of an 
example confocal image showing the analysis of contacts on CST collaterals in immediate vicinity of a contacted neuron. Arrows 
indicate boutons. (K) Left: quantification of the number of contacts per contacted neuron, presented as a cumulative frequency 
distribution (p = 0.0037, n = 138-181 contacted neurons). Right: quantification of bouton density along cervical CST collaterals in 
immediate vicinity of a contacted neuron (p = 0.0001, n = 138-181 contacted neurons). (L) 3D reconstruction of an example 
confocal image showing the analysis of mCherry-DREADD intensity within contacted neurons in Imaris. Surface rendering (in 
yellow) was performed on NeuN stained contacted neuron. (M) Left: histogram depicting the number of contacted neurons with a 
certain mCherry-DREADD intensity bin. Bin size is 100% of median intensity of all contacted neurons in control mice. 0% bin 
includes mCherry- neurons, which did not exhibit significantly higher intensities than the gray matter background (n = 368-1198 
contacted neurons). Right: quantification of mCherry intensity per contacted neuron (p < 0.0001, n = 368-1198 contacted neurons). 
(N) Experimental setup for chemogenetically silencing LPSN during detour circuit formation after a thoracic dorsal hemisection. 
(O) Confocal maximum projection of exemplary cervical gray matter showing the distribution AAV infected LPSN. (P) Left: 3D 
reconstructions of example confocal images showing the analysis of contacts onto cell bodies (left image) and dendrites (right 
image) of mCherry+ neurons. Arrows indicate contacts. Right: quantification of the total number of contacts onto mCherry+ 
neurons in mice with non-silenced (-CNO) versus silenced (+CNO) LPSN (p = 0.0312). Values are normalized to the number of 
mCherry+ neurons and CST labeling. Contacts are further grouped into cell body (-CNO: 25.4%, +CNO, 26.8%) and dendritic (-
CNO: 74.6%, +CNO, 73.2%) contacts (n = 41–134 contacts). Data in (B), (C), (D), (F), (G), (H), (I) and (P) analyzed using student’s 
t test (two-tailed, unpaired). Bar lengths represent means, and error bars represent SEMs.  Data in (K), right and (M), right 
analyzed using Mann-Whitney test. Median indicated by line. Whiskers represent the 10th and 90th percentile of mCherry intensity, 
and box borders represent the 25th and 75th percentile. Data in (K), left analyzed using Kolmogorov-Smirnov test. *p < 0.05, **p < 
0.01, ***p < 0.001 and ****p < 0.0001. Scale bars, 10µm in (B), (C), (F), (G), (J), (L) and (P); 50µm in (I); 100µm in (O). Ctrl: 
control. ns: not significant. (B)–(D) two grouped independent experiments (n = 9 mice per experimental condition) with 
experimental setup shown in (A); (F)–(J) and (L)–(M) two grouped independent experiments (n = 10-12 mice per experimental 
condition), (K) one experiment (n = 5-7 mice per experimental condition) with experimental setup shown in (E); (O)–(P) one 






To illustrate the CatWalk data and its calculated 177 parameters, we performed a PCA on 
experimental and control mice at our time point of interest, after chronic manipulation (21dpi). A two-
dimensional representation of the data with PC1 and PC2 is shown in Figure 18B. Clearly, the PCA 
separated the control mouse group from the 
experimental one, illustrating that chronic neuronal 
silencing during detour circuit establishment affects 
locomotion. More precisely, the two groups 
significantly differ in PC1 (Figure 18C), which 
explains the biggest variance in the entire data set 
(30.5%).  
Having proven the difference, we next 
evaluated, whether chronic silencing during detour 
circuit formation improves or worsens locomotor 
behavior. We applied the PCA’s calculated factor 
loadings of each parameter to each mouse’ other 
time points to investigate how their locomotor 
abilities changed over time. To reduce intrasubject 
variability, we set pre-injury PC1 for each mouse as 
a baseline value and subtracted each time point 
from it. The resulting graph shows that both groups 
perform similarly right after the injury (Figure 18D). 
However, in the chronic time point saline treated 
mice recover motor skills to approximately pre-
injury levels where CNO treated mice’ motor skills 
remain impaired. Examining the factor loadings of 
PC1, or which parameters correlate with the PC, we 
identified several functional clusters. A broad range 
of parameters belonging to gross locomotion, 
ipsilateral interlimb coordination, hindlimb paw 
shape, and the timing of paw placement all explain 
the failure of SCI mice to recover after chronic CNO 
treatment. In summary, silencing cervical 
glutamatergic neurons chronically after SCI creates 
a defective detour circuit, preventing natural 
locomotor recovery in mice. 
FIGURE 18 Selectively silencing excitatory spinal neuron 
activity prevents locomotor recovery. (A) Experimental setup 
for assessing motor skills after chemogenetically silencing 
excitatory cervical neurons during detour circuit formation after 
a thoracic dorsal hemisection. (B) PCA was applied on 177 
parameters determined by the CatWalk at 21dpi. Each mouse 
with either non-silenced (-CNO, black) or silenced (+CNO, 
orange) excitatory cervical neurons is presented with a small 
dot in a new two-dimensional PC space. Big dots represent the 
mean of each group. (C) PC1 in one dimensional PC space (p 
= 0.0140). (D) Development of PC1 over time (p = 0.0021). PC1 
was calculated for pre-injury and 3dpi time points using factor 
loadings from 21dpi. Values were normalized to pre-injury PC1. 
(E) Parameter clusters with color-coded factor loadings of PC1. 
Loadings close to 0, exhibiting low correlation with PC1 are 
coded in black, positive/negative loadings, exhibiting high 
correlation with PC1 are coded in red (scale on the right). Data 
in (C) analyzed using student’s t test (two-tailed, unpaired). Bar 
lengths represent means, and error bars represent SEMs. Data 
in (D) analyzed using repeated two-way repeated-measures 
ANOVA and a Bonferroni post hoc test; dots represent means, 
and error bars represent SEMs. *p < 0.05, **p < 0.01. pre-inj.: 
pre-injury. a.u.: arbitrary units. One experiment (n = 5-7 mice 
per experimental condition) with experimental setup shown in 








FIGURE 19 Exiting CST collaterals and similar distribution of 
AAV infected cells in control and experimental groups. (A) 
Confocal maximum projection of half of an exemplary cervical 
CST tract in mice with NMDAR functioning (-cre) versus 
nonfunctioning (+cre) cervical neurons during detour circuit 
formation. Arrows indicate exiting collaterals. Dotted line 
indicates white matter border. (B) Map showing distribution of 
GFP+ cervical neurons after AAV-GFP and AAV-GFP-cre 
injection. (C) Confocal maximum projection of half of an 
exemplary cervical CST tract in mice with CREB operational (-
aCREB) versus inhibited (+aCREB) cervical neurons during 
detour circuit formation. Arrows indicate exiting collaterals. 
Dotted line indicates white matter border. (D) Map showing 
distribution of GFP+ cervical neurons after AAV-GFP and AAV-
GFP-aCREB injection. (E) Confocal maximum projection of half 
of an exemplary cervical CST tract in mice with non-silenced (-
CNO) versus silenced (+CNO) cervical neurons (top) or 
cervical excitatory neurons (bottom) during detour circuit 
formation. Arrows indicate exiting collaterals. Dotted line 
indicates white matter border. (F) Left side: Map showing 
distribution of mCherry+ cervical neurons after AAV-DIO-
hM4Di-mCherry and AAV-GFP-cre injection into C57Bl6 mice. 
Right side: Map showing distribution of mCherry+ cervical 
neurons after AAV-DIO-hM4Di-mCherry injection into VGlut-
cre mice. Scale bars, 50µm in (A), (C), and (E); 5mm in (B), 
(D), and (F). Ctrl: control. (B) one experiment (n = 4 per 
experimental condition) with experimental setup shown in 
Figure 13C and 15A. (D) two grouped independent 
experiments (n = 4 per experimental condition) with 
experimental setup shown in Figure 14A and 16A. (F), left one 
experiment (n = 4) with experimental setup shown in Figure 
17A. (F), right one experiment (n = 4) with experimental setup 
shown in Figure 17E and 18A. Figure adapted, with permission 
from ref. 130. 
 
 setup shown in Figure 17A. (F), right one experiment with 
experimental setup shown in Figure 17E and 18A. 
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DISCUSSION 
For the first time, we provide evidence that activity dependent mechanisms guide remodeling after 
injury to the adult CNS. I formulated four thesis statements summarizing and interpreting our results to 
clarify the role of neuronal activity in CST remodeling after traumatic SCI. These statements will serve 
as a structure to the discussion of this thesis.  
1. Neuronal activity dependent processes in the spinal cord are required for appropriate target 
selection during SCI induced remodeling.  
2. There exists a critical window for activity dependent remodeling after SCI.  
3. After SCI, the sprouting motor tract selects its target neurons based on their relative neuronal 
activity.  
4. Neuronal activity in the spinal cord enables functional remodeling and allows for spontaneous 
motor recovery.  
Circuit changes in the developing and uninjured adult CNS have also been shown to rely heavily 
on activity related processes. Each of my thesis statements is, thus, complemented by a comparison of 
detour with uninjured circuit formation, in the plastic adult and developing CNS. With this comparison, I 
will show how understanding a system’s spontaneous attempt at recovery opens new possibilities for 
future research directions, novel disease intervention, and the improvement of current interventions. In 
closing, I explore the broader impact my dissertation might have on the research field of SCI, taking into 
account my chain of reasoning based on the literature analysis provided in the introduction and 
discussion, plus our research presented in the methodology and results section.  
NEURONAL ACTIVITY DEPENDENT PROCESSES IN THE SPINAL CORD 
ARE REQUIRED FOR APPROPRIATE TARGET SELECTION DURING SCI 
INDUCED REMODELING  
FIGURE 20 Interpretation of anatomic 
changes in the cervical spinal cord after 
manipulating activity dependent 
processes during detour circuit 
formation after SCI. (A) Without 
intervention the CST sprouts to contact 
unmanipulated target neurons in the 
cervical cord following a thoracic dorsal 
hemisection. (B) Left: when NMDAR in 
these target neurons are non-
functional, CST collaterals do not form 
or even lose presynaptic bouton 
structures onto those cells. Middle: 
when CREB is inhibited, CST 
collaterals do not sprout or even retract, 
which results in a loss of contacts. 
Right: CST collaterals preferentially 
contact cells with high neuronal activity, 
i.e. low DREADD induced inhibition. 
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After SCI, we manipulated three neuronal activity dependent processes and identified their role 
in detour circuit formation. All genetically induced manipulations were performed in neurons of the 
cervical spinal cord at the location and time of hindlimb CST sprouting in response to a dorsal thoracic 
hemisection (Figure 7E, Figure 20A). 126 Manipulations during detour circuit formation all resulted in a 
reduction in contacts, which are usually formed spontaneously after SCI between sprouting hindlimb 
CST collaterals and cervical spinal neurons. For the first time, we show that inhibiting the function of 
activity dependent processes produces an anatomically defective detour circuit after CNS injury.  
SYNAPTIC PLASTICITY IN THE (UN)INJURED ADULT CNS 
Synaptic changes in the adult CNS also occur spontaneously without injury. Certain synapses 
are plastic, undergoing constant changes and redefining neural circuits, which forms the basis of 
learning and memory. Similar to remodeling processes after CNS injury, adult synaptic plasticity can be 
of functional or structural origin. 138 Functional changes strengthen or weaken synapses, and during 
structural changes synapses are either formed or removed. This synaptic plasticity is governed by 
different patterns of synaptic activity, defined by an interplay between pre- and postsynaptic activity. 
Rules of synaptic plasticity in the adult uninjured CNS exhibit noteworthy similarities to our observations 
concerning synaptic changes in the injured CNS. 
Glutamate presents the main excitatory neurotransmitter in the spinal cord, 139 and it affects 
activity in the postsynaptic neuron by acting on various membrane receptors, such as NMDAR. The 
NMDAR’s high permeability to calcium upon glutamate binding is pivotal in mediating synaptogenesis. 
Stimulating postsynaptic neurons of the adult hippocampus at low frequency 140 or antagonizing 
NMDARs 141, for example, leads to a reduction in hippocampal presynaptic bouton density. This 
structural synaptic plasticity is in line with the changes we observed after manipulating NMDARs in the 
injured CNS. After knocking out the NMDAR’s crucial NR1 subunit in the cervical spinal cord during 
detour circuit formation, newly formed CST collaterals exhibited a reduction in contacts onto manipulated 
neurons (Figure 13). This effect extended to a reduction in presynaptic bouton structures on these CST 
collaterals (Figure 20B, left). NMDAR signaling is, therefore, critical for determining the number of 
boutons and the bouton’s more downstream postsynaptic target selection during the formation of detour 
circuits in the injured CNS and during synaptic plasticity in the uninjured CNS.    
Our ex vivo experimental setup does not give insight into bouton or contact dynamics. The 
observed reduction in contacts and boutons after suppressing NMDAR signaling could be explicable by 
a decreased formation or an increased elimination of synaptic structures. In vivo imaging in neuronal 
cell cultures has shown that NMDAR are recruited for synapse formation. 142 I, thus, hypothesize that 
during detour circuit formation, collaterals come into close apposition with NMDAR manipulated cervical 
neurons. The synapse, however, fails to recruit functional NMDARs to initiate the formation of a synaptic 
structure. An in vivo experiment could test this hypothesis and investigate whether adequate NMDAR 
signaling enables the formation of contacts or prevents their elimination.  
The initiation of synaptic strengthening, i.e. functional rather than structural synaptic plasticity, in 
the adult CNS also depends on NMDAR signaling. 143–145 More specifically, NMDARs are essential for 
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long-term potentiation as well as long-term depression, which are considered key mechanisms of 
synaptic strengthening in learning and memory. 146 It is conceivable that NMDARs also play a role in 
processes of synaptic strengthening in detour circuits of the injured CNS. Knocking out the NR1 subunit 
during detour circuit formation might have affected the strength of the few synapses or boutons present. 
This analysis could be based on an extension of our bouton data by moving from a binary to a continuous 
scoring of boutons; apart from analyzing whether a bouton is present or absent, we could evaluate 
relative bouton changes in fluorescence intensity or size along a CST collateral. 147 In addition, synaptic 
strength could be assessed using an electrophysiological setup, electron microscopic images could be 
taken to identify the structure of synapses, or immunohistochemical staining for synaptic markers could 
be performed.  This analysis would provide further insight into the effect NMDAR signaling exerts on the 
function of synaptic structures within SCI induced detour circuits.  
After a new contact or synapse is formed it avoids being eliminated by consolidation for long-term 
integration into a circuit. Consolidating synaptic change demands new gene transcription and protein 
synthesis. 148,149 Previous studies have shown that some transcription factors are triggered by neuronal 
activity and thereby regulate complex gene expression profiles. 150 The activity dependent transcription 
factor CREB, for example, is considered to generally ensure maintenance of synaptic stability. 151,152 
One study shows that relative CREB activity of a postsynaptic neuron determines its likelihood of being 
recruited into a memory trace. 151 Thus, where NMDAR signaling is involved in the initial stages of 
synaptic plasticity, i.e. synapse formation and initial strengthening, consolidation of synaptic change is 
determined by CREB activity.   
CREB also plays a role in detour circuit formation following SCI (Figure 14). Inhibiting CREB 
resulted in a decrease in contacts between CST collaterals and manipulated cervical neurons, similar 
to the effects observed after NMDAR inhibition (Figure 20B, middle). Functional CREB mediated 
transcription and NMDAR signaling in the postsynaptic neuron are, thus, required for appropriate target 
finding of the remodeling CST after SCI.  However, general CST collateral morphology, aside from 
contacts onto target neurons, is differentially shaped by these two activity dependent processes (Figure 
20B, left and middle). In contrast to NMDAR inhibition, blocking CREB did not affect CST collateral 
bouton densities. In addition, we only observed a reduction in CST collateral branches innervating the 
cervical gray matter after blocking CREB. These differences in anatomic alterations illustrate that 
NMDAR and CREB do not function interchangeably but have slightly different roles in the activity 
dependent formation of detour circuits following SCI.  
Taking together previous knowledge on synaptic plasticity in the uninjured CNS, I propose a 
model where a sequence of structural changes during detour circuit formation is determined by activity 
dependent processes. After a thoracic injury, CST collaterals sprout and form boutons close to neurons 
with functional NMDAR signaling. Afterwards, this bouton can mature into a synapse if a neuron with 
strong NMDAR signaling is contacted. The extent of CREB transcription, then, determines whether this 
contact together with its collateral branch is stabilized or not. Thus, when NMDAR signaling is inhibited, 
collaterals fail to initiate bouton formation and to find neurons to make contacts with. Remarkably, at our 
time of analysis, these CST collaterals remain in the cervical spinal cord, almost as if they were still 
searching for appropriate target neurons. It would be interesting to test, whether this anatomic state of 
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dense collaterals without boutons is permanent, or if, at some point, collaterals might be removed. When 
CREB is inhibited, I hypothesize that boutons and contacts form normally through functioning NMDAR 
signaling; only later, the CREB inhibited postsynaptic neuron fails to stabilize these contacts together 
with CST collaterals. These remodeled structures are consequently removed. I argue that in both, the 
uninjured and injured CNS, functional NMDAR signaling is necessary for the initiation of synaptic change 
and CREB for its consolidation.  
PRUNING IN THE DEVELOPING AND INJURED CNS 
Naturally, synaptic changes dominate not only adjustments within the adult CNS but also the 
CNS’ entire development. During developmental circuit formation an excessive number of synapses is 
formed before synaptic elimination removes unnecessary synapses, whilst crucial ones are stabilized. 
This mechanism of establishing mature connectivity is called pruning and has been demonstrated in 
various locations of the CNS - at the neuromuscular junction, 153 in the visual 154,155 and olfactory system, 
156 and in the cerebellum. 157 Pruning is a mechanism for synaptic target selection in the developing 
CNS.  
Several studies in the developing CNS reveal the role of NMDAR signaling in pruning. 
Pharmacological intervention or genetic deletion of postsynaptic NMDAR 158–162 during development has 
been observed to impair synaptic pruning. All circuits exhibited aberrant synaptic patterning after 
inhibiting NMDARs. For example, deleting the NR1 subunit in the developing cortex, abolishes the 
somatotopic organization of the rodent barrel cortex. 158,161 Even in the developing peripheral nervous 
system, reducing NMDAR activation affects synaptic pruning on skeletal muscles. Usually, a muscle 
fiber is initially innervated by a large group of motor neurons, which reduces to innervation by one motor 
neuron later in development – a process significantly slowed down by decreasing NMDAR function. 162 
These developmental studies show that NMDARs are crucial for adequate pruning by eliminating 
unnecessary connections and establishing mature synaptic patterning.  
Pruning also occurs during detour circuit formation after SCI. In our investigated detour circuit, for 
example, previous data shows that after a thoracic hemisection CST collaterals sprout cervically and 
contact two populations of PSN, long and short ones. In contrast to LPSN, short PSN do not have 
connections to the lumbar target area of the lesioned CST and, thus, lack the potential to aid in motor 
recovery. At a later time point, during the pruning phase, unnecessary synapses onto short PSN get 
eliminated, whilst contacts onto LPSN are maintained. 126 The formation of excessive synaptic 
connections together with the later deletion of unnecessary ones determine the wiring of a mature detour 
circuit after CNS injury.  
The mechanisms of pruning in detour circuits remain poorly understood. During detour circuit 
formation, our knockout of an NDMAR subunit led to a decrease in contacts between remodeling CST 
collaterals and the manipulated neurons. It would be interesting to investigate if our manipulation 
restricted to short PSN, during pruning of detour circuits, would affect contact numbers similarly. Due to 
the effects of NMDAR dysfunction on synapses during developmental pruning, it is conceivable that our 
manipulation would induce more contacts of sprouting CST collaterals onto spinal neurons because of 
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a failure to eliminate superfluous synapses onto the short PSN subpopulation. Experiments into the 
mechanisms of pruning could highlight how more contacts within a detour circuit does not necessarily 
lead to functional improvements, but that it is crucial for the system to differentiate between meaningful 
and meaningless connections to avoid maladaptive responses.  
THERE EXISTS A CRITICAL WINDOW FOR ACTIVITY DEPENDENT 
REMODELING AFTER SCI  
Next, we determined if the investigated circuitry was sensitive to the manipulation of activity 
dependent processes continuously, by varying the time of intervention. When manipulations occurred 
during the formation of detour circuits around two to three weeks post injury a defective detour circuit 
was created; manipulations in a mature detour circuit (Figure 15) or an intact one (Figure 16), however, 
did not impact circuitry. These results show that detour circuits only respond to changes in activity 
dependent processes with plasticity during a limited period of time after SCI.  
Whilst plasticity in some areas of the CNS, like those associated with memory formation, reaches 
far into adulthood, the majority of areas lose their capacity to adapt after they have been fully 
established. In the cat visual system, for example, Hubel and Wiesel were the first to show that closing 
one eye and preventing it from exciting neurons during the first few months of life creates a visual cortex 
mainly representing the nondeprived eye.  163 This effect, however, is only exerted when the eye is 
closed in infant cats. Reopening the eye at a later time point does not reverse the anatomic effects. 
Thus, activity dependent plasticity in this area in cats is restricted to a certain period or critical window 
during development and infancy. Ocular dominance plasticity in the visual system is just one classical 
example of activity dependent circuit refinement that is temporally restricted to a developmental period; 
each CNS structure of each species has its own individual critical window. Only within this activity 
dependent critical window, can the different regions of the nervous system tailor their circuitry to the 
environment; after closing, circuitry in those regions remains unaffected by changes in activity.   
Some researchers have linked the age dependent reduction in plasticity in certain regions of the 
CNS to a decline in CREB activity 164,165 and change in NMDAR function. 166,167 Further external 
suppression of these activity dependent processes in these mature areas would, thus, be in vain. 
Similarly, suppressing CREB in the cervical cord without injury did not affect forelimb CST collaterals 
and their contacts onto neurons in this region (Figure 16). Hence, adult CST circuitry is not per se plastic 
in the mature cervical cord or, at least, its plasticity does not depend on CREB function. In contrast, the 
suppression of CREB or NMDAR function around three weeks after SCI, severely affected hindlimb CST 
collaterals and their contacts onto neurons in this area. These experiments show that activity dependent 
remodeling and plasticity are reintroduced in specific areas through CNS injury. The cervical spinal cord, 
though, does not remain indefinitely plastic; later (twelve weeks post injury) manipulations of the NMDAR 
left the detour circuit unaltered. Together these data suggest that SCI reopens a critical window of 
plasticity and remodeling transiently, recapitulating developmental processes of activity, CREB and 




It is important to note that these studies merely prove the existence of a critical window without 
defining its exact borders; it opens somewhere between directly after until two weeks after injury and 
closes between three and twelve weeks post injury. In order to narrow these periods down, more densely 
timed experiments would need to be conducted. For the design of SCI therapies that alter activity 
dependent processes in humans, it will also be important to determine the exact borders of the critical 
window. Remodeling will likely be most susceptible to interventions during this critical window.  
Furthermore, it could be clinically relevant to explore whether established strategies that can 
reopen the critical window of developmental plasticity can be similarly employed to extend the phase of 
remodeling related plasticity after CNS injury. When a critical window can be reactivated, the application 
of interventions becomes less time sensitive. Interventions, then, do not need to be restricted to 
individuals with novel SCIs and immediate access to state-of-the-art medicine.  Interestingly, the glial 
scar associated inhibitory factor, chondroitin sulphate proteoglycan, does not only impair axonal 
outgrowth in the injured CNS. Chondroitin sulphate proteoglycans have also been shown to inhibit the 
above described ocular dominance plasticity. Neutralizing these chondroitin sulphate proteoglycans in 
adult rodents with chondroitinase ABC reactivates the state of ocular dominance plasticity where the 
visual system is anatomically altered by monocular deprivation. 168 The success of chondroitinase ABC 
as a treatment for SCI might, hence, stem from a reopening of a critical window of remodeling related 
plasticity. Thus, extending or reactivating the critical period of plasticity during the formation of detour 
circuits after SCI, using remodeling supportive interventions such as chondroitinase ABC, and pairing 
these interventions with a manipulation of activity dependent processes might support remodeling 
beyond previous measurements.   
AFTER SCI, THE SPROUTING MOTOR TRACT SELECTS ITS TARGET 
NEURONS BASED ON THEIR RELATIVE NEURONAL ACTIVITY 
As a final anatomic assessment, we investigated the effect of direct silencing with DREADDs of 
different populations of cervical neurons during detour circuit formation (Figure 17). Global cervical 
silencing, irrespective of the neuronal population, did not alter the examined detour circuit. However, 
silencing neuronal activity similarly but specifically in glutamatergic cells or LPSN, which are normally 
contacted by remodeling CST collaterals, produced an anatomically defective detour circuit (Figure 20B, 
right). Further analyses after this manipulation revealed that DREADD levels determine each neuron’s 
likelihood of being recruited for the emerging detour circuit. These results show that the effect of 
silencing neurons in the area of remodeling motor tracts after SCI depend on which neuronal population 
is targeted by the manipulation.  
During synaptic refinement in development and synaptic plasticity in the adult uninjured CNS, 
global and selective manipulations of activity dependent processes have also been observed to affect 
circuitry differentially. For example, in hippocampal cultures, suppressing activity in a single neuron 
decreases its synaptic inputs, whereas broader populational suppression does not affect synapse 
formation.  169 In addition, nonuniform manipulations within a neuronal population provides further insight 
into plasticity determined by activity dependent processes. This experimental approach allows to relate 
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manipulation levels to the likelihood of a neuron to be integrated into a circuit. On a presynaptic level, 
for example, it was shown that axons compete to innervate a target by differences in relative neuronal 
activity. 170 Furthermore, as stated before, relative CREB function in potential target neurons determines 
which neurons will be integrated into an adult uninjured circuit.  151 This research suggests that is not 
total network activity that shapes circuitry. Rather, in the developing and adult, uninjured CNS, individual 
neurons within an eligible neuronal population compete for the integration into a circuit by relative 
strengths of activity dependent processes.  
These experimental approaches and results from uninjured CNS compare to the ones from the 
injured CNS presented in this thesis. The contrast in anatomic effects by specific rather than global 
silencing indicates that spinal neurons are integrated into a detour circuit based on their relative activity. 
Silencing all neurons does not give one neuronal population a competitive advantage over another 
because total network activity rather than individual relative activity is reduced. However, specific 
silencing of cervical glutamatergic neurons or LPSN, which are usually contacted by remodeling 
collaterals, creates a defective detour circuit. These silenced populations exhibit less remodeled 
contacts because they have been set at a clear disadvantage to receive essential CST input. This 
interpretation is further supported by measuring the virally mediated mosaic expression of DREADDs 
within contacted neurons after glutamatergic silencing.  We show that the higher the DREADD 
expression or the more silenced a neuron, the less likely it is to be contacted. We even observed a 
compensation effect, where after glutamatergic silencing CST collaterals increased their contacts onto 
unmanipulated neurons. In conclusion, after CNS injury, target selection during detour circuit formation 
is less determined by total network activity than by relative activity of an individual neuron and its 
competitors. Due to the comparable effect of silencing LPSN and glutamatergic neurons, I further 
postulate that this same rule of relative activity dependence similarly applies to the integration of all 
potential target cells. These interpretations suggest that measures to increase activity in a suitable 
neuronal population would be more promising in enhancing contact formation onto those neurons after 
SCI than bluntly increasing total network activity.  
Our work demonstrates for the first time, that one can link relative DREADD expression levels to 
prominent anatomic alterations. How DREADD expression correlates with levels of neuronal silencing 
exactly is unclear. One hypothesis is simply that CNO can activate more DREADDs in high expressing 
cells and, therefore, induce stronger levels of hyperpolarization than in low expressing cells at a given 
moment. Another option is that highly expressing cells are silenced over a longer period of time, whilst 
neurons with lower DREADD expression levels are silenced more briefly due to a lack of receptor 
reserve. 171,172 Electrophysiological experiments or staining for markers of neuronal activity could shed 
light onto whether the degree of hyperpolarization or its duration is the driving force in our observed 





NEURONAL ACTIVITY IN THE SPINAL CORD ENABLES FUNCTIONAL 
REMODELING AND ALLOWS FOR SPONTANEOUS MOTOR RECOVERY  
As stressed in the introduction of this thesis, functional assessment is indispensable when 
interpreting the effect of interventions. Using the CatWalk, we could show that the defect created by the 
manipulation of activity dependent processes during detour circuit formation was not limited to anatomy. 
More specifically, silencing glutamatergic neurons in the cervical spinal cord led to mice with chronically, 
up to three weeks post injury, impaired fine motor skills.   
Firstly, this behavioral data identifies another circuit component crucial for spontaneous motor 
recovery after SCI. Anatomic remodeling alone does not imply functional improvements. In contrast, 
anatomic remodeling can even include miswiring, which causes further behavioral impairments like 
spasticity. Until now, relesioning the CST after a dorsal hemisection has only proven the motor tract’s 
general ability to induce recovery, irrespective of the new connections it forms. 126 For the first time, we 
could show that the integration of cervical glutamatergic neurons into a detour circuit is key in functional 
remodeling after incomplete SCI.  
It is possible that the CST is not the only remodeling motor tract that contacts cervical 
glutamatergic neurons. Thus, silencing those neurons might have a broader impact on other detour 
circuits, and the observed behavioral impairment results from a general decrease of contacts from 
several motor tracts. Unfortunately, there is no established technique, yet, to truly assign behavioral 
changes to the examined detour circuit; one would need to specifically silence or ablate a substantial 
number of synapses between hindlimb CST collaterals and cervical glutamatergic neurons.  
The second insight gained from this experiment concerns the impact of neuronal activity 
dependent processes on functional remodeling after SCI. Anatomically, we observed the CST’s attempt 
to compensate for the contact loss onto silenced cervical glutamatergic neurons by increasingly 
contacting unsilenced neurons. However, this anatomic effect does not result in a functional 
compensation, and mice with silenced glutamatergic neurons remain motorically impaired without 
exhibiting signs of spontaneous motor recovery. This seeming deviation could be explained in the 
anatomy, by the number of compensatory contacts being marginal or by the formation of superfluous 
contacts onto non-glutamatergic neurons that do not aid in functional recovery. By decreasing the viral 
infection rate in the cervical spinal cord, one could test if there is a percentage of silenced glutamatergic 
neurons, at which the detour circuit is able to compensate for a certain contact loss successfully, in 
terms of anatomy and function. Without these additional experiments, we can still conclude that 
glutamatergic neuronal activity at the location of motor tract sprouting after SCI is indispensable for 
spontaneous motor recovery. 
Aberrant activity dependent processes have also been associated with functional deficits in the 
uninjured CNS; they have even been implicated in the etiology of several neurodevelopmental and 
neuropsychiatric disorders. 173,174 Increasing activity dependent processes like NMDAR 175–181 or CREB 
182,183 function, on the contrary, has been applied to support synaptic plasticity and induce cognitive 
improvements. The enhanced performance of rodents was elicited in learning and memory tasks, such 
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as fear conditioning, fear memory, fear extinction, novel-object recognition, spatial memory, and working 
memory. Even in humans, upregulating NMDAR function has been observed to enhance performance 
in learning tasks. 184 Therefore, boosting activity dependent processes in the adult uninjured CNS is a 
promising approach to improve plastic processes and amplify functional abilities.  
In my opinion, the most insightful follow-up study of our research investigates if increasing activity 
dependent processes in the injured CNS can also improve anatomic and functional remodeling. The 
first approach could be to increase downstream processes of neuronal activity, like NMDAR signaling 
and CREB transcription, in the cervical spinal cord after SCI. Secondly, our newly gained knowledge 
could aid in improving our methods of increasing neuronal activity directly as a potential treatment option 
for SCI. As described in the introduction of this thesis, a general increase of neuronal activity through 
rehabilitative training, electrostimulation, or pharmacological stimulation can improve locomotor 
recovery after CNS injury. In addition, a recent paper has shown that decreasing neuronal activity of 
spinal inhibitory neurons through DREADDs promotes functional recovery. 135 Combining these data 
with ours, their observed effect might have been induced by an increase in relative activity of 
glutamatergic neurons, placing them at a competitive advantage of receiving input from remodeling 
motor tracts.  It remains to be revealed if targeting the increase of activity dependent processes to 
neurons, which are spontaneously contacted by remodeling collaterals of a detour circuit could further 
strengthen connectivity and improve functional recovery after SCI.  
CLOSING REMARKS 
In the introduction of my thesis, I have used previous studies to show that SCI is a devastating 
disease with far reaching implications and little prospect of relief for the individual affected and their 
community. The physiological and psychological impairments result from a damaging cascade induced 
at the injury site, leading to axon degeneration, demyelination, ischemia, cell death, inflammation and 
excitotoxicity. Unfortunately, the CNS fails to recover by regeneration during which axons attempt to 
regrow past the injury in vain. I have evaluated interventions that support axon regeneration as 
challenging because (1) the number of regenerating fibers and regeneration lengths achieved, so far, 
are limited, (2) regeneration itself without the formation of contacts cannot induce functional 
improvements, and (3) some of the observed functional improvements stem from off-target effects on 
remodeling, distal to the injury site.  
Remodeling is the basis for the limited functional recovery we observe across species after 
incomplete SCI, and I have, thus, argued that it is a promising research field to design disease 
intervention. A detailed literature analysis on anatomic remodeling in rodents after SCI together with a 
presentation of the limitations of current interventions trying to boost remodeling, has underlined the 
importance to deepen our knowledge on processes involved in the spontaneous formation of detour 
circuits. Promising interventions, such as, pharmacological stimulation, epidural stimulation or 
neurorehabilitation converge in their effect of increasing neuronal activity in the spinal cord. We set out 
to investigate the exact impact neuronal activity dependent processes have on the formation of a well 
described detour circuit. This detour circuit is induced after a thoracic hemisection. Here, the CST 
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sprouts cervically to contact spinal neurons, such as LPSN. These neurons travel below the hemisection 
and contact initial target motoneurons of the injured CST, in the lumbar spinal cord.  
By inhibiting NMDAR signaling, CREB function, and neuronal activity itself in the cervical spinal 
cord, we have shown that remodeling CST collaterals choose their target neurons based on the relative 
activity of these processes during a critical window of detour circuit formation. In addition to the anatomic 
regulation of remodeling, these activity dependent processes also enable functional remodeling and, 
thus, spontaneous locomotor recovery after SCI. Using these results, I have claimed that activity 
dependent neuronal competition guides functional and anatomic remodeling after CNS injury.   
In the discussion, parallels between activity dependent neuroplasticity in the uninjured and injured 
CNS were drawn. A detailed literature analysis on plasticity in the developing and uninjured adult CNS 
has given rise to suggestions for future experiments that evaluate if certain observations extend to the 
spinal cord injured CNS. I have argued that the most urgent follow-up study would investigate if 
increasing activity dependent processes in a specific neuronal population during the critical window after 
SCI would boost remodeling and motor recovery.  
In our study, we have unraveled some of the mechanisms by which the CNS partially and 
spontaneously compensates for SCI. Anatomic and functional remodeling after incomplete SCI is guided 
by activity dependent processes. Taken together, I have shown that deepening our understanding of a 
system’s spontaneous attempt at recovery, such as remodeling after CNS injury, identifies potential 
pitfalls that need to be considered when assessing treatment options and opens new possible entry 
points for the design of novel interventions.  
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